<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="systematic-review" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Psychiatry</journal-id>
<journal-id journal-id-type="publisher-id">Front. Psychiatry</journal-id>
<journal-title-group>
<journal-title>Frontiers in Psychiatry</journal-title>
</journal-title-group>
<issn pub-type="epub">1664-0640</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30804820</article-id>
<article-id pub-id-type="pmc">6378305</article-id>
<article-id pub-id-type="doi">10.3389/fpsyt.2019.00034</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Psychiatry</subject>
<subj-group>
<subject>Systematic Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Systematic Review of Gut Microbiota and Major Depression</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Cheung</surname>
<given-names>Stephanie G.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/679059/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Goldenthal</surname>
<given-names>Ariel R.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/674422/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Uhlemann</surname>
<given-names>Anne-Catrin</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/317189/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mann</surname>
<given-names>J. John</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Miller</surname>
<given-names>Jeffrey M.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/64181/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sublette</surname>
<given-names>M. Elizabeth</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/230624/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Division of Consultation-Liaison Psychiatry, Columbia University</institution>, <addr-line>New York, NY</addr-line>, <country>United States</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Psychiatry, Columbia University</institution>, <addr-line>New York, NY</addr-line>, <country>United States</country></aff>
<aff id="aff3"><sup>3</sup><institution>Molecular Imaging &amp; Neuropathology Area, New York State Psychiatric Institute</institution>, <addr-line>New York, NY</addr-line>, <country>United States</country></aff>
<aff id="aff4"><sup>4</sup><institution>Division of Infectious Diseases, Department of Medicine, Columbia University</institution>, <addr-line>New York, NY</addr-line>, <country>United States</country></aff>
<aff id="aff5"><sup>5</sup><institution>Microbiome &amp; Pathogen Genomics Core, Columbia University</institution>, <addr-line>New York, NY</addr-line>, <country>United States</country></aff>
<aff id="aff6"><sup>6</sup><institution>Department of Radiology, Columbia University</institution>, <addr-line>New York, NY</addr-line>, <country>United States</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Andrea Fagiolini, Università degli Studi di Siena, Italy</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Tanya T. Nguyen, University of California, San Diego, United States; Gal Winter, University of New England, Australia</p>
</fn>
<corresp id="c001">*Correspondence: M. Elizabeth Sublette <email>Elizabeth.Sublette@nyspi.columbia.edu</email></corresp>
<fn fn-type="other" id="fn001">
<p>This article was submitted to Mood and Anxiety Disorders, a section of the journal Frontiers in Psychiatry</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>11</day>
<month>2</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>10</volume>
<elocation-id>34</elocation-id>
<history>
<date date-type="received">
<day>07</day>
<month>8</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>21</day>
<month>1</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2019 Cheung, Goldenthal, Uhlemann, Mann, Miller and Sublette.</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>Cheung, Goldenthal, Uhlemann, Mann, Miller and Sublette</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p><bold>Background:</bold> Recently discovered relationships between the gastrointestinal microbiome and the brain have implications for psychiatric disorders, including major depressive disorder (MDD). Bacterial transplantation from MDD patients to rodents produces depression-like behaviors. In humans, case-control studies have examined the gut microbiome in healthy and affected individuals. We systematically reviewed existing studies comparing gut microbial composition in MDD and healthy volunteers.</p>
<p><bold>Methods:</bold> A PubMed literature search combined the terms “depression,” “depressive disorder,” “stool,” “fecal,” “gut,” and “microbiome” to identify human case-control studies that investigated relationships between MDD and microbiota quantified from stool. We evaluated the resulting studies, focusing on bacterial taxa that were different between MDD and healthy controls.</p>
<p><bold>Results:</bold> Six eligible studies were found in which 50 taxa exhibited differences (<italic>p</italic> &lt; 0.05) between patients with MDD and controls. Patient characteristics and methodologies varied widely between studies. Five phyla—<italic>Bacteroidetes, Firmicutes, Actinobacteria, Fusobacteria</italic>, and <italic>Protobacteria</italic>—were represented; however, divergent results occurred across studies for all phyla. The largest number of differentiating taxa were within phylum <italic>Firmicutes</italic>, in which nine families and 12 genera differentiated the diagnostic groups. The majority of these families and genera were found to be statistically different between the two groups in two identified studies. Family <italic>Lachnospiraceae</italic> differentiated the diagnostic groups in four studies (with an even split in directionality). Across all five phyla, nine genera were higher in MDD (<italic>Anaerostipes, Blautia, Clostridium, Klebsiella, Lachnospiraceae incertae sedis, Parabacteroides, Parasutterella, Phascolarctobacterium</italic>, and <italic>Streptococcus</italic>), six were lower (<italic>Bifidobacterium, Dialister, Escherichia/Shigella, Faecalibacterium</italic>, and <italic>Ruminococcus</italic>), and six were divergent (<italic>Alistipes, Bacteroides, Megamonas, Oscillibacter, Prevotella</italic>, and <italic>Roseburia</italic>). We highlight mechanisms and products of bacterial metabolism as they may relate to the etiology of depression.</p>
<p><bold>Conclusions:</bold> No consensus has emerged from existing human studies of depression and gut microbiome concerning which bacterial taxa are most relevant to depression. This may in part be due to differences in study design. Given that bacterial functions are conserved across taxonomic groups, we propose that studying microbial functioning may be more productive than a purely taxonomic approach to understanding the gut microbiome in depression.</p>
</abstract>
<kwd-group>
<kwd>depression</kwd>
<kwd>gut</kwd>
<kwd>microbiome</kwd>
<kwd>microbiota</kwd>
<kwd>gut-brain axis</kwd>
</kwd-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="3"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="153"></ref-count>
<page-count count="17"></page-count>
<word-count count="12823"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Major Depressive Disorder (MDD) is a debilitating psychiatric illness affecting an estimated 300 million people worldwide (<xref ref-type="bibr" rid="B1">1</xref>). MDD is the leading cause of disability globally (<xref ref-type="bibr" rid="B2">2</xref>) and is associated with ~800,000 suicide deaths annually (<xref ref-type="bibr" rid="B3">3</xref>). Despite significant advances in our understanding of the etiology of MDD (<xref ref-type="bibr" rid="B4">4</xref>), existing knowledge is incomplete, treatments are inadequate, and new insights into MDD pathophysiology are urgently needed. One novel area of investigation related to MDD pathophysiology is the gut microbiome.</p>
<p>The microbiome is a collection of trillions of microorganisms, including bacteria, that inhabit and interact with human hosts, with effects ranging from beneficial to pathogenic (<xref ref-type="bibr" rid="B5">5</xref>), and also more specifically refers to the collection of microbiota and their genetic material (<xref ref-type="bibr" rid="B6">6</xref>). Groups of bacteria are organized on a phylogenetic tree with taxonomical categories ranging from low resolution (kingdom, phylum) to high resolution (genus, species) taxa.</p>
<p>The gut microbiota are considered so necessary and so integrated into host function that some describe this population as an overlooked organ (<xref ref-type="bibr" rid="B7">7</xref>). Beyond the breakdown of otherwise indigestible food substances and production of micronutrients, gut microbiota affect the hypothalamic-pituitary-adrenal axis (HPA) (<xref ref-type="bibr" rid="B8">8</xref>), produce neurologically active substances such as gamma-aminobutyric acid (GABA) (<xref ref-type="bibr" rid="B9">9</xref>) and short-chain fatty acids (SCFAs) (<xref ref-type="bibr" rid="B10">10</xref>), and influence the immune system and gut barrier (<xref ref-type="bibr" rid="B11">11</xref>–<xref ref-type="bibr" rid="B16">16</xref>).</p>
<p>A growing body of literature supports and characterizes a gut-brain axis, and elucidates a possible role of gut microbiome dysfunction in major depression. Associations between the gut microbiome and depression have been identified in studies of inflammatory states and gut barrier health (<xref ref-type="bibr" rid="B17">17</xref>–<xref ref-type="bibr" rid="B19">19</xref>). In addition, animal studies have supported the possibility of a causative role of dysbiosis (disruption of the microbiome) in depression-like behaviors. Broad-spectrum antibiotic administration in mice leads to dysbiosis, depression-like behavior, and altered neuronal hippocampal firing, with reversal of this phenotype following probiotic treatment with <italic>Lactobacillus casei DG</italic> (<xref ref-type="bibr" rid="B20">20</xref>). Male germ-free mice also exhibit elevated levels of serotonin (5-hydroxytryptamine) and its metabolite, 5-hydroxyindoleacetic acid in the hippocampus (<xref ref-type="bibr" rid="B21">21</xref>). Few translational studies are as dramatic as the human-to-rodent studies in which transplantation of gut microbiota from humans with MDD to germ-free or microbiota-deficient rodents induces a depression-like phenotype, including anhedonia and anxiety-like behaviors, not observed in mice receiving microbiota transplantation from healthy controls (<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B23">23</xref>). A small number of human studies have demonstrated behavioral correlates of dysbiosis ranging from infant colic (<xref ref-type="bibr" rid="B24">24</xref>) to behavioral abnormalities in neurodevelopmental disorders (<xref ref-type="bibr" rid="B25">25</xref>). Finally, several studies have compared the gut microbiome in affected vs. control individuals. In order to investigate the role of the gut microbiome in MDD, we systematically reviewed the scientific literature of case-control studies concerning gut microbiome composition in MDD.</p>
</sec>
<sec id="s2" sec-type="methods">
<title>Methods</title>
<sec>
<title>Literature Search for Gut Microbiome Studies in MDD</title>
<p>To identify putative depression-relevant aspects of gut microbiome composition, a PubMed literature search was performed that included articles published prior to February 28, 2018 with combinations of the terms “depression,” “depressive disorder,” “stool,” “fecal,” “gut,” and “microbiome.” Additional relevant articles were sought through manual bibliography search. Eligibility criteria were: (<xref ref-type="bibr" rid="B1">1</xref>) articles in English; (<xref ref-type="bibr" rid="B2">2</xref>) human case-control studies; (<xref ref-type="bibr" rid="B3">3</xref>) articles focused on depression; and (<xref ref-type="bibr" rid="B4">4</xref>) gut microbiota quantified from stool samples. Two raters (SGC and ARG) reviewed all search results and came to a consensus about inclusion/exclusion of each article.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec>
<title>Literature Search to Identify Human Case-Controlled Studies</title>
<p>Six studies met the search criteria (<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B26">26</xref>–<xref ref-type="bibr" rid="B30">30</xref>), involving a total of 392 research participants, 204 MDD and 188 controls (see <xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>Flow chart of literature search for articles concerning case-control studies of the gut microbiome in major depressive disorder compared with healthy volunteers.</p>
</caption>
<graphic xlink:href="fpsyt-10-00034-g0001"></graphic>
</fig>
</sec>
<sec>
<title>Characteristics of the Studies</title>
<sec>
<title>Sample (see <xref ref-type="table" rid="T1">Tables 1</xref>, <xref ref-type="table" rid="T2">2</xref> for More Details)</title>
<p>Five of the six identified case-control studies were conducted in Asia: four in China and one in Japan. The sixth study was conducted in Norway. The sample sizes of the studies were relatively small, ranging from 10 to 63 individuals per diagnostic group. Three of the studies documented smoking status, but the number of active smokers was not matched between diagnostic groups.</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Population characteristics.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Study</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Country</bold>
</th>
<th align="center" colspan="2" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>Sample size</bold>
</th>
<th align="center" colspan="2" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>% Female</bold>
</th>
<th align="center" colspan="2" rowspan="1" style="border-bottom: thin solid #000000;" valign="top"><bold>Age (Mean</bold>
<bold>±</bold><italic><bold>SD</bold></italic><bold>)</bold></th>
<th align="center" colspan="2" rowspan="1" style="border-bottom: thin solid #000000;" valign="top"><bold>BMI (Mean</bold>
<bold>±</bold><italic><bold>SD</bold></italic><bold>)</bold></th>
<th align="center" colspan="2" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>% Smoking</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Mean baseline depression severity</bold>
</th>
</tr>
<tr>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>MDD</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Control</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>MDD</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Control</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>MDD</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Control</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>MDD</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Control</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>MDD</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Control</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>(MDD)</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Naseribafrouei et al. (<xref ref-type="bibr" rid="B26">26</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Norway</td>
<td align="center" colspan="1" rowspan="1" valign="top">37</td>
<td align="center" colspan="1" rowspan="1" valign="top">18</td>
<td align="center" colspan="1" rowspan="1" valign="top">54.1</td>
<td align="center" colspan="1" rowspan="1" valign="top">61.1</td>
<td align="center" colspan="1" rowspan="1" valign="top">49.2 ± 13.9</td>
<td align="center" colspan="1" rowspan="1" valign="top">46.1 ± 13.9</td>
<td align="center" colspan="1" rowspan="1" valign="top">25.9 ± 4.2</td>
<td align="center" colspan="1" rowspan="1" valign="top">24.7 ± 3.3</td>
<td align="center" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="center" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">MADRS<break></break> 26.3 ± 7.6</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Jiang et al. (<xref ref-type="bibr" rid="B27">27</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">China</td>
<td align="center" colspan="1" rowspan="1" valign="top">A-MDD 29<break></break> R-MDD 17</td>
<td align="center" colspan="1" rowspan="1" valign="top">30</td>
<td align="center" colspan="1" rowspan="1" valign="top">A-MDD 37.9<break></break> R-MDD 47.0</td>
<td align="center" colspan="1" rowspan="1" valign="top">50.0</td>
<td align="center" colspan="1" rowspan="1" valign="top">A-MDD 25.3 ± 5.4<break></break> R-MDD 27.1 ± 5.4</td>
<td align="center" colspan="1" rowspan="1" valign="top">26.8 ± 5.4</td>
<td align="center" colspan="1" rowspan="1" valign="top">A-MDD 20.3 ± 3.4<break></break> R-MDD 21.8 ± 3.4</td>
<td align="center" colspan="1" rowspan="1" valign="top">19.6 ± 3.4</td>
<td align="center" colspan="1" rowspan="1" valign="top">A-MDD 10%<break></break> R-MDD 12%</td>
<td align="left" colspan="1" rowspan="1" valign="top">7%</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-MDD<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref><break></break> HAM-24<break></break> 29.8 ± 7.6<break></break> MADRS<break></break> 27.4 ± 8.5</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Aizawa et al. (<xref ref-type="bibr" rid="B28">28</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Japan</td>
<td align="center" colspan="1" rowspan="1" valign="top">43</td>
<td align="center" colspan="1" rowspan="1" valign="top">57</td>
<td align="center" colspan="1" rowspan="1" valign="top">41.9</td>
<td align="center" colspan="1" rowspan="1" valign="top">61.4</td>
<td align="center" colspan="1" rowspan="1" valign="top">39.4 ± 10.0</td>
<td align="center" colspan="1" rowspan="1" valign="top">42.8 ± 12.7</td>
<td align="center" colspan="1" rowspan="1" valign="top">23.2 ± 3.6</td>
<td align="center" colspan="1" rowspan="1" valign="top">22.3 ± 3.7</td>
<td align="center" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="center" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">HAM-21<break></break> 16.9 ± 6.8</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Zheng et al. (<xref ref-type="bibr" rid="B23">23</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">China</td>
<td align="center" colspan="1" rowspan="1" valign="top">58</td>
<td align="center" colspan="1" rowspan="1" valign="top">63</td>
<td align="center" colspan="1" rowspan="1" valign="top">62.1</td>
<td align="center" colspan="1" rowspan="1" valign="top">63.5</td>
<td align="center" colspan="1" rowspan="1" valign="top">40.6 ± 11.7</td>
<td align="center" colspan="1" rowspan="1" valign="top">41.8 ± 12.3</td>
<td align="center" colspan="1" rowspan="1" valign="top">22.0 ± 2.4</td>
<td align="center" colspan="1" rowspan="1" valign="top">22.6 ± 2.5</td>
<td align="center" colspan="1" rowspan="1" valign="top">18%</td>
<td align="center" colspan="1" rowspan="1" valign="top">26%</td>
<td align="left" colspan="1" rowspan="1" valign="top">HAM-17<break></break> 22.8 ± 4.4</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Lin et al. (<xref ref-type="bibr" rid="B29">29</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">China</td>
<td align="center" colspan="1" rowspan="1" valign="top">10</td>
<td align="center" colspan="1" rowspan="1" valign="top">10</td>
<td align="center" colspan="1" rowspan="1" valign="top">40.0</td>
<td align="center" colspan="1" rowspan="1" valign="top">40.0</td>
<td align="center" colspan="1" rowspan="1" valign="top">36.2 ± 10.1</td>
<td align="center" colspan="1" rowspan="1" valign="top">38.1 ± 2.9</td>
<td align="center" colspan="1" rowspan="1" valign="top">23.8 ± 1.9</td>
<td align="center" colspan="1" rowspan="1" valign="top">24.2 ± 2.0</td>
<td align="center" colspan="1" rowspan="1" valign="top">40%</td>
<td align="center" colspan="1" rowspan="1" valign="top">30%</td>
<td align="left" colspan="1" rowspan="1" valign="top">HAM-17 ≥ 23</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Chen et al. (<xref ref-type="bibr" rid="B30">30</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">China</td>
<td align="center" colspan="1" rowspan="1" valign="top">10</td>
<td align="center" colspan="1" rowspan="1" valign="top">10</td>
<td align="center" colspan="1" rowspan="1" valign="top">50.0</td>
<td align="center" colspan="1" rowspan="1" valign="top">50.0</td>
<td align="center" colspan="1" rowspan="1" valign="top">43.9 ± 13.8</td>
<td align="center" colspan="1" rowspan="1" valign="top">39.6 ± 9.0</td>
<td align="center" colspan="1" rowspan="1" valign="top">23.5 ± 2.0</td>
<td align="center" colspan="1" rowspan="1" valign="top">22.6 ± 1.5</td>
<td align="center" colspan="1" rowspan="1" valign="top">0%</td>
<td align="center" colspan="1" rowspan="1" valign="top">0%</td>
<td align="left" colspan="1" rowspan="1" valign="top">HAM 25.6 ± 4.7</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>A-MDD, active-major depressive disorder; R-MDD, recovering-MDD who exhibited 50% reduction in HAM score after treatment; BMI, body-mass index; HAM, Hamilton depression rating scale; MADRS, Montgomery-Åsberg depression rating scale.</p>
<fn id="TN1">
<label>*</label>
<p><italic>Baseline mean depression severity for R-MDD not provided</italic>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T2" position="float">
<label>Table 2</label>
<caption>
<p>Methodologic characteristics of the articles reviewed.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Study</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Genetic analysis</bold>
</th>
<th align="center" colspan="2" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>Diversity assessments</bold>
</th>
<th align="center" colspan="3" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>MDD</bold>
</th>
<th align="center" colspan="3" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>Pooled population</bold>
</th>
</tr>
<tr>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>α- Diversity</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>β-Diversity</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>% on AD; AD treatment</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Diagnostic/severity determination</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Depression severity inclusion criteria</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Medical history</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Antibiotic usage</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Probiotic, prebiotic, synbiotic usage</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Naseribafrouei et al. (<xref ref-type="bibr" rid="B26">26</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Illumina deep sequencing of 16S gene amplicons Region: unspecified Pipeline analysis: QIIME Database: RDB Cut-off: 1% Closed-reference picking</td>
<td align="left" colspan="1" rowspan="1" valign="top">Species richness Simpson's D</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">73% on medications</td>
<td align="left" colspan="1" rowspan="1" valign="top">Research Criteria of the ICD-10/MADRS</td>
<td align="left" colspan="1" rowspan="1" valign="top">None</td>
<td align="left" colspan="1" rowspan="1" valign="top">Included control participants with diffuse neurological symptoms, but who were not found to have cerebral disorders after neurological examination, CT, and MRI. One control participant (6%) was on antidepressant medication.</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">N/A</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Jiang et al. (<xref ref-type="bibr" rid="B27">27</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">454 pyrosequencing of the 16S rRNA gene Region: V1–V3 Pipeline analysis: Mothur Database: RDB Cut-off: 3% Closed- or open-reference picking unspecified</td>
<td align="left" colspan="1" rowspan="1" valign="top">Shannon Simpson Evenness ACE Chao1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Principal Coordinate Analysis of Unweighted UniFrac distances</td>
<td align="left" colspan="1" rowspan="1" valign="top">A-MDD: 72% on SSRIs or SNRI, 24% on atypical antipsychotic, 83% on benzodiazepine R-MDD: 100% on SSRI or SNRI, 29% on atypical antipsychotic, 58.9% on benzodiazepine</td>
<td align="left" colspan="1" rowspan="1" valign="top">MINI used as screening for preexisting psychiatric disorders, SCID DSM IV / HAM-24, MADRS</td>
<td align="left" colspan="1" rowspan="1" valign="top">HAM-17 score ≥ 20</td>
<td align="left" colspan="1" rowspan="1" valign="top">Excluded individuals with hypertension, cardiovascular disease, diabetes mellitus, obesity, liver cirrhosis, fatty liver disease, irritable bowel syndrome, inflammatory bowel disease, known active bacterial, fungal or viral infections. Excluded MDD participants with other psychiatric disorders, drug, or alcohol abuse in the last year. Excluded control participants with psychiatric or physical illnesses.</td>
<td align="left" colspan="1" rowspan="1" valign="top">No use of antibiotics month prior to fecal sample</td>
<td align="left" colspan="1" rowspan="1" valign="top">No prebiotic or synbiotic use in the month prior to fecal sample</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Aizawa et al. (<xref ref-type="bibr" rid="B28">28</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Yakult Intestinal Flora-SCAN® bacterial 16 S rRNA-targeted RT-qPCR</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">65%; average imipramine equivalent dose = 187.7 ± 152.7 mg/day</td>
<td align="left" colspan="1" rowspan="1" valign="top">Interviewed using MINI and unstructured interview, DSM IV/HAM-21</td>
<td align="left" colspan="1" rowspan="1" valign="top">None</td>
<td align="left" colspan="1" rowspan="1" valign="top">Excluded individuals with history of central nervous system disease or any severe medical condition, substance abuse or dependence, mental retardation, history of surgery on the GI system, or severe congenital abnormality. Excluded control participants with current or past history of psychiatric illness or contact with psychiatric services. 48.3% of MDD group had IBS and 14% of control group had IBS using the Rome III Criteria.</td>
<td align="left" colspan="1" rowspan="1" valign="top">No recent antibiotic use</td>
<td align="left" colspan="1" rowspan="1" valign="top">5 individuals used probiotics</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Zheng et al. (<xref ref-type="bibr" rid="B23">23</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">16S rRNA gene sequencing using Illumina HiSeq2500 Region: V3–V5 Pipeline analysis: Mothur Database: RDB Cut-off: 3% Closed- or open-reference picking unspecified</td>
<td align="left" colspan="1" rowspan="1" valign="top">Observed species Shannon Phylogenetic diversity Simpson</td>
<td align="left" colspan="1" rowspan="1" valign="top">Weighted Bray-Curtis similarity Principal Coordinate Analysis of Unweighted UniFrac distances</td>
<td align="left" colspan="1" rowspan="1" valign="top">33%; paroxetine (3), duloxetine venlafaxine, citalopram (3), mirtazapine, sertraline, fluoxetine, and ”others“ (8)</td>
<td align="left" colspan="1" rowspan="1" valign="top">SCID DSM IV TR/HAM-17</td>
<td align="left" colspan="1" rowspan="1" valign="top">None</td>
<td align="left" colspan="1" rowspan="1" valign="top">Excluded MDD candidates who had a history of substance abuse, were pregnant, nursing or currently menstruating. Control participants were excluded if they had evidence of systemic medical illness, mental disorder or family history of psychiatric disorder.</td>
<td align="left" colspan="1" rowspan="1" valign="top">Not currently taking</td>
<td align="left" colspan="1" rowspan="1" valign="top">Not currently taking</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Lin et al. (<xref ref-type="bibr" rid="B29">29</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">16S rRNA gene sequencing using Illumina MiSeq sequences Region: V3-V4 Pipeline analysis: Mothur Database: Silva v.119 Cut-off: 3% Closed- or open-reference picking unspecified</td>
<td align="left" colspan="1" rowspan="1" valign="top">ACE Chao Shannon Simpson</td>
<td align="left" colspan="1" rowspan="1" valign="top">Principal Coordinate Analysis of weighted UniFrac distances</td>
<td align="left" colspan="1" rowspan="1" valign="top">100%; escitalopram 10 mg/day</td>
<td align="left" colspan="1" rowspan="1" valign="top">DSM-IV TR/HAM-17</td>
<td align="left" colspan="1" rowspan="1" valign="top">HAM-17 ≥ 23</td>
<td align="left" colspan="1" rowspan="1" valign="top">Included control participants with good physical and mental health, no stomach or gut problems.</td>
<td align="left" colspan="1" rowspan="1" valign="top">None within last month</td>
<td align="left" colspan="1" rowspan="1" valign="top">None within last month</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Chen et al. (<xref ref-type="bibr" rid="B30">30</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Metaproteomics: phylogenetic analysis of the bacterial peptides</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">40%; 20% on SSRI or SNRI, 20% on atypical antipsychotics</td>
<td align="left" colspan="1" rowspan="1" valign="top">SCID DSM IV / HAM (version not specified)</td>
<td align="left" colspan="1" rowspan="1" valign="top">HAM &gt; 20</td>
<td align="left" colspan="1" rowspan="1" valign="top">Excluded participants who had pre-existing physical or other mental illnesses, history of drug or alcohol abuse, family history of any psychiatric disorder, infectious disease, gastrointestinal diseases, irritable bowel syndrome, inflammatory bowel disease, diabetes, obesity, smoking, and excluded females who were pregnant, nursing or menstruating.</td>
<td align="left" colspan="1" rowspan="1" valign="top">Not currently taking</td>
<td align="left" colspan="1" rowspan="1" valign="top">Not currently taking</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>AD, anti-depressant; HAM, Hamilton depression rating scale (17, 21, or 24 item); ICD, international statistical classification of diseases and related health problems; MADRS, Montgomery-Åsberg depression rating scale; MINI, mini-international neuropsychiatric interview; SCID, structured clinical interview for DSM disorders; SSRI, selective serotonin reuptake inhibitor; SNRI, serotonin-norepinephrine reuptake inhibitor</italic>.</p>
</table-wrap-foot>
</table-wrap>
<sec>
<title>Medication and use of probiotics/prebiotics/synbiotics</title>
<p>All studies included participants taking psychiatric medications. The percentage of individuals in the MDD group on antidepressant medication ranged from 33 to 100% among the six studies. While the majority of studies included individuals on a variety of antidepressant medications, Lin et al. (<xref ref-type="bibr" rid="B29">29</xref>) standardized the treatment to 10 mg of escitalopram per day. Of note, two studies (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B30">30</xref>) included individuals being treated with antipsychotics. All but one study (<xref ref-type="bibr" rid="B26">26</xref>) excluded individuals on antibiotics within at least the last month. Three studies specifically excluded recent probiotic use (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B30">30</xref>), and one of these studies also excluded recent prebiotic or synbiotic use (<xref ref-type="bibr" rid="B27">27</xref>); however, five participants in one study (<xref ref-type="bibr" rid="B28">28</xref>) were on probiotics.</p>
</sec>
<sec>
<title>Psychiatric and medical conditions</title>
<p>Exclusion criteria related to psychiatric and medical conditions differed among the six studies. All but one (<xref ref-type="bibr" rid="B26">26</xref>) excluded a variety of specific medical illnesses or stipulated no active disease. Zheng et al. (<xref ref-type="bibr" rid="B23">23</xref>), problematically, excluded medical illness only in the controls. Some of the studies specified exclusion of individuals with other psychiatric history. For example, Aizawa et al. (<xref ref-type="bibr" rid="B28">28</xref>) excluded those with a history of substance use disorder and intellectual disability. Naseribafrouei et al. (<xref ref-type="bibr" rid="B26">26</xref>), did not recruit healthy volunteers but instead recruited controls with diffuse neurological symptoms who were not diagnosed with any neurological condition after physical examination and imaging. One study (<xref ref-type="bibr" rid="B27">27</xref>) recruited only MDD participants with scores &gt;20 on the 24-item HAM at baseline but then divided the sample into responders and non-responders after 4 weeks of treatment with respect to microbiome findings.</p>
</sec>
</sec>
<sec>
<title>Methodology (see <xref ref-type="table" rid="T2">Table 2</xref>)</title>
<sec>
<title>Clinical assessments</title>
<p>Diagnostic methods included the International Classification of Disease 10 (ICD 10), the Mini-International Neuropsychiatric Interview (MINI), and the Structural Clinical Interview for DSM-IV (SCID). Depression severity was assessed variously by the Montgomery-Åsberg Depression Rating Scale (MADRS) and the Hamilton Depression Rating Scale (HAM). The majority of studies used the HAM (17, 21, and 24-item scales) to determine severity, whereas one study (<xref ref-type="bibr" rid="B26">26</xref>) used the ICD 10 and MADRS for severity measurements. Mean depression levels in all six studies were of moderate to high severity (see <xref ref-type="table" rid="T1">Table 1</xref>).</p>
</sec>
<sec>
<title>Microbiome quantification</title>
<p>All but one of the studies included used 16S rRNA gene sequencing, but with different region specification: region V1–V3 (<xref ref-type="bibr" rid="B27">27</xref>), region V3–V5 (<xref ref-type="bibr" rid="B23">23</xref>), region V3–V4 (<xref ref-type="bibr" rid="B29">29</xref>), no specified region (<xref ref-type="bibr" rid="B26">26</xref>), and a bacterial rRNA-targeted reverse transcription-quantitative polymerase chain reaction (RT-qPCR) method with no specified region (<xref ref-type="bibr" rid="B28">28</xref>). For pipeline analysis, one study used Quantitative Insights Into Microbial Ecology (QIIME) with a cut-off of 1% and closed-reference picking (<xref ref-type="bibr" rid="B26">26</xref>), and three used Mothur with a dissimilarity cut-off of 3% (<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B29">29</xref>). Three of the studies (<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>) used the Ribosomal Database Project (RDP) database, while a fourth used the Silva v.119 database (<xref ref-type="bibr" rid="B29">29</xref>). A single study (<xref ref-type="bibr" rid="B30">30</xref>) performed metaproteomic analysis using identified bacterial proteins with hierarchical clustering analysis of orthologous groups to differentiate MDD from controls, followed by phylogenetic analysis of the bacterial peptides and, with respect to Bacteroidetes and Firmicutes only, taxonomic distribution into genus and species (see <xref ref-type="table" rid="T2">Table 2</xref> for more details).</p>
</sec>
<sec>
<title>Diversity assessments</title>
<p>All four studies assessing α-diversity (within-sample diversity) utilized the Simpson diversity index (<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B29">29</xref>), and all but one (<xref ref-type="bibr" rid="B26">26</xref>) also used the Shannon index. Two studies (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B29">29</xref>) additionally estimated richness with abundance-based estimators, the Abundance-based Coverage Estimator (ACE) and Chao1. Generic measures for evenness (<xref ref-type="bibr" rid="B27">27</xref>), observed species richness (<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B26">26</xref>) and phylogenetic diversity (<xref ref-type="bibr" rid="B23">23</xref>) were also mentioned.</p>
<p>Estimates of β-diversity (diversity of microbial community structure) employed included weighted Bray-Curtis similarity (<xref ref-type="bibr" rid="B23">23</xref>), and principal coordinate analysis of weighted (<xref ref-type="bibr" rid="B29">29</xref>) and unweighted (<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B27">27</xref>) UniFrac distances.</p>
</sec>
<sec>
<title>Statistical analysis</title>
<p>To distinguish MDD from control groups, a variety of techniques was used, ranging from classical statistics to machine learning approaches. These included the following: Student's t- and Wilcoxon's signed-rank Tests (<xref ref-type="bibr" rid="B29">29</xref>), Mann–Whitney tests (<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B30">30</xref>), the linear discriminant analysis effect size method (<xref ref-type="bibr" rid="B27">27</xref>), principal component analysis (PCA) (<xref ref-type="bibr" rid="B26">26</xref>), and the Random Forest algorithm (<xref ref-type="bibr" rid="B23">23</xref>).</p>
</sec>
<sec>
<title>Functional analyses</title>
<p>Only the most recent investigation (<xref ref-type="bibr" rid="B30">30</xref>) employed methodology allowing a functional assessment of the gut microbiome. They directly measured fecal protein levels by performing high performance liquid chromatography followed by mass spectrometry, identifying non-redundant proteins on the basis of two unique peptides and filtering out human proteins. The resulting proteins were classified using the Cluster of Orthologous Groups database (138,458 proteins from 66 genomes that have been classified into 23 functional categories) in order to predict function in the gut microbiome.</p>
</sec>
</sec>
<sec>
<title>Synthesized Findings (see <xref ref-type="table" rid="T3">Table 3</xref>)</title>
<p>Combining these studies, 50 taxa were significantly (<italic>p</italic> &lt; 0.05) different between MDD and controls. On the phylum level, these six studies identified the following phyla as being significantly different between the two groups: <italic>Bacteroidetes, Firmicutes, Actinobacteria, Fusobacteria</italic>, and <italic>Protobacteria</italic>. Phylum <italic>Firmicutes</italic> had the largest number of taxa (nine families) found to be significantly different between MDD and controls. On the family level, <italic>Lachnospiracea</italic> was found to be significantly different between the two groups in four studies, however, two were higher and two lower in direction. All studies identified taxa at the genus level, finding 21 genera that distinguished the diagnostic groups, as follows: nine genera were higher in MDD (<italic>Anaerostipes, Blautia, Clostridium, Klebsiella, Lachnospiraceae incertae sedis, Parabacteroides, Parasuterella, Phascolarctobacterium</italic>, and <italic>Streptococcus</italic>), six were lower (<italic>Bifidobacterium, Dialister, Escherichia/Shigella, Faecalibacterium</italic>, and <italic>Ruminococcus</italic>), and six had findings in both directions (<italic>Alistipes, Bacteroides, Megamonas, Oscillibacter, Prevotella</italic>, and <italic>Roseburia</italic>). Genera identified by more than one report as elevated in MDD were <italic>Alistipes, Blautia, Oscillibacter</italic> and <italic>Clostridium</italic>, although <italic>Alistipes</italic> and <italic>Oscillibacter</italic> also had one report each of being lower. Only <italic>Faecalibacterium</italic> had two reports of being lower in MDD.</p>
<table-wrap id="T3" position="float">
<label>Table 3</label>
<caption>
<p>Taxa with disparate representation in depressed vs. non-depressed humans in six case-controlled studies quantifying gut microbiome from feces.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Phylum</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Class</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Order</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Family</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Genus</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Actinobacteria</italic><break></break> ↑Chen<break></break> ↓Jiang</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Coriobacteridae</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Coriobacteriales</italic><break></break> ↑Zheng</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Coriobacteriaceae</italic><break></break> ↑Zheng</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Bifidonbacteriales</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Bifidobacteriaceae</italic><break></break> ↑Chen</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Bifidobacterium</italic><break></break> ↓Aizawa</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Actinomycetales</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Streptomycetaceae</italic><break></break> ↑Chen</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Actinomycetaceae</italic><break></break> ↑Chen</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Nocardiaceae</italic><break></break> ↑Chen</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Bacteroidetes</italic><break></break> ↑Jiang<break></break> ↑ Naseribafrouei<break></break> ↓Chen<break></break> ↓Lin</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Bacteroidia</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Bacteroidales</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Rikenellaceae</italic><break></break> ↑Jiang <break></break>↔Chen</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Alistipes</italic><break></break> ↑Jiang<break></break> ↑Naseribafrouei<break></break> ↓Zheng</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Prevotellaceae</italic><break></break> ↓Jiang (A-MDD)<break></break> ↓Chen</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Prevotella</italic><break></break> ↑Lin<break></break> ↓Jiang</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Bacteroidaceae</italic><break></break> ↑Jiang (R-MDD)<break></break> ↓Jiang (A-MDD)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Bacteroides</italic><break></break> ↑Jiang (R-MDD)<break></break> ↓Jiang (A-MDD)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Porphyromonadaceae</italic><break></break> ↑Jiang <break></break>↔Chen</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Parabacteroides</italic><break></break> ↑Jiang</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Sphingobacteria</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Sphingobacteriales</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Chitinophagaceae</italic><break></break> ↓Chen</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Marniabilaceae</italic><break></break> ↓Chen</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Firmicutes</italic><break></break> ↑Chen<break></break> ↓Jiang<break></break> ↑Lin</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Clostridia</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Clostridiales</italic>↑Zheng</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Lachnospiraceae</italic><break></break> ↑Chen<break></break> ↑Zheng<break></break> ↓Jiang<break></break> ↓Naseribafrouei</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Lachnospiraceae incertae sedis</italic><break></break> ↑Jiang (A-MDD)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Anaerostipes</italic><break></break> ↑Zheng</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Blautia</italic><break></break> ↑Jiang (A-MDD)<break></break> ↑Zheng</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Roseburia</italic><break></break> ↑Jiang<break></break> ↓Zheng</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Oscillospiraceae</italic><break></break> ↓Chen</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Oscillibacter</italic><break></break> ↑Jiang (A-MDD)<break></break> ↓Jiang (R-MDD)<break></break> ↑Naseribafrouei</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Ruminococcaceae</italic><break></break> ↑Chen<break></break> ↑Zheng<break></break> ↓Jiang (R-MDD)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Faecalibacterium</italic><break></break> ↓Jiang<break></break> ↓Zheng</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Ruminococcus</italic><break></break> ↓Jiang</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Clostridiaceae</italic><break></break> ↑Chen</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Clostridium</italic> (XIX+IX)<break></break> ↑Jiang (A-MDD)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">↑Lin</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Unclassified<break></break> ↑Zheng</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Negativicutes</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Selenomonadales</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Veillonellaceae</italic><break></break> ↓Jiang</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Megamonas</italic><break></break> ↑Jiang (A-MDD)<break></break> ↓Zheng</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Dialister</italic><break></break> ↓Jiang</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Acidaminococcaceae</italic><break></break> ↑Jiang<break></break> ↓Zheng</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Phascolarctobacterium</italic><break></break> ↑Jiang</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Erysipelotrichia</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Eerysipelotrichales</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Erysipelotrichaceae</italic><break></break> ↑Chen<break></break> ↓Jiang (A-MDD)<break></break> ↑Zheng</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Bacilli</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Lactobacillus</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Streptococcaceae</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Streptococcus</italic><break></break> ↑Lin</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Fusobacteria</italic><break></break> ↑Jiang (A-MDD)<break></break> ↓Jiang (R-MDD)</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Fusobacteriia</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Fusobacteriales</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Fusobacteriaceae</italic><break></break> ↑Jiang (A-MDD)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Proteobacteria</italic><break></break> ↑Jiang (A-MDD)<break></break> ↓Chen<break></break> ↓Jiang (R-MDD)</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Gammaproteobacteria</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Enterobacteriales</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Enterobacteriaceae</italic><break></break> ↑Jiang<break></break> ↓Chen</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Escherichia</italic>/<italic>Shigella</italic><break></break> ↓Jiang (R-MDD)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Klebsiella</italic><break></break> ↑Lin</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Betaproteobacteria</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Burkholderiales</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Sutterellaceae</italic><break></break> ↓Chen</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Parasutterella</italic><break></break> ↑Jiang (A-MDD)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>Only taxa whose differences reached statistical significance (p ≤ 0.05) were selected</italic>.</p>
<p><italic>↑, increased in depression; ↓, decreased in depression; ↔, direction not deciphered; A-MDD, Active-MDD; R-MDD, recovering-MDD exhibited 50% reduction in Hamilton Depression Score after treatment. If “Jiang” is mentioned without identifying A-MDD or R-MDD, both exhibited the same directionality</italic>.</p>
</table-wrap-foot>
</table-wrap>
<p>Results differed between the four studies that compared α-diversity between groups (<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>). One study (<xref ref-type="bibr" rid="B27">27</xref>) reported statistically significant higher α-diversity with respect to one (Simpson's index) of multiple estimators used, in MDD who did not respond to treatment, but not in the group of treatment-responsive MDD, compared with controls (5.344 in non-responders vs. 5.038 in controls). A second study (<xref ref-type="bibr" rid="B26">26</xref>) found no differences between MDD and controls with respect to species richness (374 ± 56 vs. 351 ±42, respectively) or Simpson's index for α-diversity (39.5 ± 15.9 vs 34.4 ± 19.6); however, their control group was not healthy volunteers but rather patients with diffuse neurological complaints. The third study (<xref ref-type="bibr" rid="B23">23</xref>) found no differences in α-diversity, while the final study described α-diversity measures in the Methods section but did not report any findings (<xref ref-type="bibr" rid="B29">29</xref>).</p>
<p>Three studies analyzed and compared β-diversity. One (<xref ref-type="bibr" rid="B27">27</xref>) was not able to obtain an estimate of phylogenetic β-diversity due to large inter-individual variability. Two studies reported a difference between MDD and controls with respect to β-diversity: one (<xref ref-type="bibr" rid="B23">23</xref>) using unweighted UniFrac analysis (eigenvalues 19, 7.2, 5.5%), and the other (<xref ref-type="bibr" rid="B29">29</xref>) using weighted UniFrac analysis (eigenvalues 8.6 and 6.8%).</p>
<p>According to the Cluster of Orthologous Group classifications, Chen et al. (<xref ref-type="bibr" rid="B30">30</xref>) found the four most striking group differences in fecal bacterial protein levels in the categories of translation, ribosomal structure and biogenesis; carbohydrate transport and metabolism; energy production and conversion; and inorganic ion transport and metabolism (in descending order of magnitude).</p>
</sec>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<sec>
<title>Main Findings</title>
<p>All studies reviewed found significant differences in taxa between MDD and control groups, and one study additionally demonstrated that fecal transplantation from MDD patients into mice induced depressive-like behaviors (<xref ref-type="bibr" rid="B23">23</xref>). However, there was minimal consensus with regard to either microbial diversity or relative abundance or directionality of differences in taxa associated with MDD.</p>
</sec>
<sec>
<title>Sources of Bias</title>
<sec>
<title>Methodologic Differences</title>
<p>Likely accounting for some of the discordance among studies is discrepant methodology (see <xref ref-type="table" rid="T2">Table 2</xref>). The use of metaproteomics and phylogenetic analysis of bacterial peptides in one study (<xref ref-type="bibr" rid="B30">30</xref>) affects comparability with the other studies, which used 16S RNA quantification. Furthermore, in contrast to most of the studies, two articles limited their search of the gut microbiome <italic>a priori</italic> to specific taxa: Firmicutes and Bacteroidetes (<xref ref-type="bibr" rid="B30">30</xref>) or Bifidobacterium and Lactobacillus (<xref ref-type="bibr" rid="B28">28</xref>). Even though most studies used high throughput sequencing of 16S rRNA, the analysis methods involved different variable regions, different pipelines, different databases, and different cut-offs, which may each influence results to varying degrees. Moreover, analytic methods differed widely among the studies. Statistical methodology for microbiome analysis has not been standardized across the field, and many approaches have been noted to be prone to high false discovery rates (<xref ref-type="bibr" rid="B31">31</xref>), a concern addressed specifically by only two studies (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B30">30</xref>).</p>
</sec>
<sec>
<title>Sample Differences</title>
<p>Although strong population homogeneity was a within-study strength, different population characteristics across studies contribute to difficulties in comparability. For example, geographic/ethnic dietary differences (<xref ref-type="bibr" rid="B32">32</xref>), as well as differences in host genetics, immune characteristics, and behavioral factors within each geographic population may be expected to affect the gut microbiome directly. Differences in microbial composition vary considerably by geographical location (<xref ref-type="bibr" rid="B33">33</xref>). In fact, regional differences within a single province in China were found to be the strongest phenotypic determinant of microbiome variability in a large sample (<italic>N</italic> = 7,009) of similar ancestry (99% Han Chinese), accounting for five-fold more variance than the next most relevant of the 30 attributes studied (<xref ref-type="bibr" rid="B34">34</xref>). Thus, a signal associated with depression would need to account for enough variance to be detected in the context of all these other effects. Of note, a study of regionally heterogeneous participants did find a signal for mental illness status that was reproducible among subsets by region, although the mental illness status was determined by self-report and covered several conditions in addition to depression (<xref ref-type="bibr" rid="B33">33</xref>).</p>
<p>Small sample sizes, as low as only 10 individuals per diagnostic group in two studies (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B30">30</xref>), limit confidence in the results. Additionally, exclusion criteria varied among the six studies with respect to medical conditions. This may have resulted in heterogeneity within the control groups, as systemic inflammation due to medical conditions could be associated with differences in the microbiota between individuals.</p>
<p>The use of medications in all the studies included in this review is likely to also have had an impact on the gut microbiome. In particular, there is evidence in the literature that antipsychotics may impact the microbiome. For example, atypical antipsychotics are associated with altered gut microbiota in rodents (<xref ref-type="bibr" rid="B35">35</xref>–<xref ref-type="bibr" rid="B37">37</xref>). In a study of bipolar adults (<xref ref-type="bibr" rid="B38">38</xref>), significant changes in the abundance of three genera were identified between those taking vs. not taking antipsychotics. The inclusion of individuals on antipsychotics in two of the six studies (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B30">30</xref>), therefore, contribute to the problems inherent in comparing these studies. In addition, one of the studies included individuals using probiotics (<xref ref-type="bibr" rid="B28">28</xref>), which may influence the composition of the gut microbiome, improve gut wall function, and influence immune system signaling (<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B40">40</xref>).</p>
</sec>
</sec>
<sec>
<title>Mechanisms Through Which the Microbiota may be Associated With Psychopathology</title>
<p>Like the six articles reviewed here, many studies of the microbiome have focused on the relative abundance of specific microbial operational taxonomic units (OTUs) and health outcomes of interest. However, looking for specific taxa as a marker of disease may miss important information for certain conditions. Although a great number of microbial taxa are found in the human gut microbiome, a limited number will take up niches in any one individual. For example, over 1,000 bacterial species were identified in a sample of 124 subjects. Each individual's feces harbored at least 160 species, but much of the bacterial DNA coded for similar processes (<xref ref-type="bibr" rid="B41">41</xref>). Gut microbiome distribution across individuals demonstrates surprisingly low convergence even between individuals on identical diets (<xref ref-type="bibr" rid="B42">42</xref>), in accord with evidence of conserved metabolic processes across taxa (<xref ref-type="bibr" rid="B43">43</xref>). This suggests that different individuals can have taxonomically varied but functionally similar microbiota, i.e., the same or similar essential functions can be performed by a variety of microbial taxa. Likewise, varied permutations of microbial communities can take up nutritional and locational niches depending on opportunity and environment (<xref ref-type="bibr" rid="B6">6</xref>). With respect to exploration of the gut microbiome's effects on depression, understanding microbial functions may therefore be more illuminating than focusing on relative abundance of specific taxa. Chen et al. (<xref ref-type="bibr" rid="B30">30</xref>), the most recent of the reviewed articles, attempted to address this by employing a proteomic analysis method to produce comparative functional assessment based on the identified bacterial proteins. The impact of this article is necessarily limited by the problem of generalizing from a very small sample size (<italic>n</italic> = 10 MDD/10 controls).</p>
<p>Fundamental bacterial functions involve consumption of substrates and production of metabolites (<xref ref-type="bibr" rid="B44">44</xref>). A taxon's specific pattern of substrate and nutrient usage may shed light on its survival fitness in certain environments and its ability to use available materials for products, some of which may be relevant to depression. Bacteria often demonstrate symbiotic relationships with other taxa, metabolizing substrates into products which may benefit themselves, feed or otherwise benefit their neighbors and host, or influence/signal their neighbors and host (<xref ref-type="bibr" rid="B44">44</xref>). Of particular interest with respect to depression etiology are products that can interact with the nervous systems (central and enteral) or play a role in immune responses such as inflammation. Gut microbiota benefit the host in multiple ways, include digesting/fermenting carbohydrates, producing micronutrients, mounting immune responses to discourage colonization by pathogens (<xref ref-type="bibr" rid="B45">45</xref>), and producing a variety of neuroactive molecules (<xref ref-type="bibr" rid="B46">46</xref>). Thus, multiple possible pathways exist whereby the microbiome may either contribute to or confer resilience against depression. Some instances are explored below.</p>
<sec>
<title>Bacterial Metabolism of Carbohydrates and Proteins</title>
<p>Dietary carbohydrates, including indigestible oligosaccharides, are a common substrate for gut bacteria, which transform them into short chain fatty acids (SCFAs), including acetate, propionate, butyrate, and valerate. These substances serve as energy sources for the host and for other bacterial species (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B47">47</xref>). SCFAs also trigger differentiation of T cells (<xref ref-type="bibr" rid="B48">48</xref>) and can function as histone deacetylase inhibitors, which as a class have immunosuppressive (<xref ref-type="bibr" rid="B49">49</xref>) and anti-inflammatory (<xref ref-type="bibr" rid="B50">50</xref>–<xref ref-type="bibr" rid="B52">52</xref>) functions and have been proposed as potential novel antidepressants (<xref ref-type="bibr" rid="B53">53</xref>). Additionally SCFAs activate G protein-coupled receptors (<xref ref-type="bibr" rid="B49">49</xref>), are involved in neurotransmitter production (<xref ref-type="bibr" rid="B54">54</xref>) and neuroprotection (<xref ref-type="bibr" rid="B55">55</xref>, <xref ref-type="bibr" rid="B56">56</xref>), and can themselves penetrate the blood-brain barrier (<xref ref-type="bibr" rid="B57">57</xref>). We looked broadly at reports of SCFA production among the reviewed case-control studies and found that in general the genera <italic>reduced</italic> in MDD have extensive capacity to metabolize carbohydrates, particularly mono- and disaccharides and their derivatives [<italic>Bifidobacterium</italic> (<xref ref-type="bibr" rid="B58">58</xref>–<xref ref-type="bibr" rid="B62">62</xref>), <italic>Faecalibacterium</italic> (<xref ref-type="bibr" rid="B63">63</xref>), and <italic>Ruminococcus</italic> (<xref ref-type="bibr" rid="B64">64</xref>–<xref ref-type="bibr" rid="B66">66</xref>)]. <italic>Bacteroides</italic>, found to be reduced in a treatment-nonresponsive depressed subgroup compared to healthy controls (<xref ref-type="bibr" rid="B27">27</xref>), as a genus has a particularly rich armamentarium for metabolizing more complex carbohydrates including glycans of human mucin (<xref ref-type="bibr" rid="B67">67</xref>–<xref ref-type="bibr" rid="B78">78</xref>).</p>
<p>In contrast, although some of the genera reported as <italic>elevated</italic> in MDD also can metabolize carbohydrates [<italic>Anaerostipes</italic> (<xref ref-type="bibr" rid="B79">79</xref>), <italic>Blautia</italic> (<xref ref-type="bibr" rid="B80">80</xref>), <italic>Clostridium</italic> (<xref ref-type="bibr" rid="B65">65</xref>, <xref ref-type="bibr" rid="B81">81</xref>, <xref ref-type="bibr" rid="B82">82</xref>)] it may be noteworthy that several are high metabolizers of amino acids and proteins [<italic>Clostridium</italic> (<xref ref-type="bibr" rid="B83">83</xref>, <xref ref-type="bibr" rid="B84">84</xref>), <italic>Klebsiella</italic> (<xref ref-type="bibr" rid="B84">84</xref>), <italic>Parabacteroides</italic> (<xref ref-type="bibr" rid="B85">85</xref>), <italic>Streptococcus</italic> (<xref ref-type="bibr" rid="B83">83</xref>), <italic>Oscillibacter</italic> and <italic>Alistipes</italic> (<xref ref-type="bibr" rid="B84">84</xref>)]. Increased metabolism of proteins by microbiota involves fermentation, or bacterial putrefaction, a process that may divert essential host amino acids from the host to the microbes and may result in toxic products such as ammonia, putrescine, and phenol (<xref ref-type="bibr" rid="B84">84</xref>). Dysbiosis that results in increased putrefaction has been implicated in the pathogenesis of colorectal cancer (<xref ref-type="bibr" rid="B84">84</xref>) and autism spectrum disorders (<xref ref-type="bibr" rid="B86">86</xref>). With regard to depression, in a large epidemiologic study, elevated dietary intake of protein at baseline was associated with more severe depressive symptoms at 10-year follow-up in a dose-dependent manner, in women only (<xref ref-type="bibr" rid="B87">87</xref>). Others have reported that interactions between dietary protein levels and genetic polymorphisms can moderate the risk of depression (<xref ref-type="bibr" rid="B88">88</xref>).</p>
<p>Thus, while not quantitatively testable across the studies reviewed here, we may speculate that dysbiosis resulting in a relatively lower capacity to metabolize carbohydrates and higher capacity for protein metabolism may have a role in the pathogenesis of MDD. Lower SCFA could contribute to symptomatology as a result of lower energy and altered neurotransmission, while both lower SCFA and higher putrefaction products are implicated in intestinal inflammation, relevant here as inflammatory bowel conditions have been associated with a high co-morbidity with depression and anxiety (<xref ref-type="bibr" rid="B89">89</xref>). We have focused our discussion on mechanisms through which dysbiosis could contribute to the development of depression. However, the directionality of the associations between inflammatory bowel disease and depression is not known. Thus, it is also plausible that depression may cause digestive problems and dysbiosis either through altered dietary choices or other mechanisms. One hypothesis could be that in some individuals, depression confers a decreased ability to digest proteins; the resulting increased residual protein in the colon would give an advantage to higher concentrations of microbes which prefer proteins as substrates, leading to higher putrefaction and inflammation.</p>
</sec>
<sec>
<title>Production of Micronutrients</title>
<p>Water-soluble vitamins from the diet may be absorbed from the small intestine, including ascorbate (vitamin C), biotin (B7), folate (B9), niacin (B3), pantothenic acid (B5) pyridoxine (B6), riboflavin (B2), and thiamine (B1) (<xref ref-type="bibr" rid="B90">90</xref>). However, a number of these water-soluble vitamins also can be generated by microbiota and absorbed in the colon and thereby affect the host (<xref ref-type="bibr" rid="B90">90</xref>). Therefore, dysbiosis resulting in low production of micronutrients could contribute to depression pathophysiology, particularly in the case of depressed patients with poor nutritional intake. For example, <italic>Bifidobacterium</italic>, among the genera that were less abundant in MDD in reviewed case-control studies, can synthesize riboflavin, niacin, and folate (<xref ref-type="bibr" rid="B91">91</xref>). Low folate levels have been associated with the presence of depression by meta-analysis (<xref ref-type="bibr" rid="B92">92</xref>), and folate levels were inversely associated with depressive symptom severity in one epidemiological study (<xref ref-type="bibr" rid="B93">93</xref>). The relative contribution of dietary <italic>vs</italic>. bacterial folate to the host is not clear (<xref ref-type="bibr" rid="B90">90</xref>); however, a carrier for uptake of folate into human colonocytes has been described in cell culture (<xref ref-type="bibr" rid="B94">94</xref>) and <italic>ex vivo</italic> (<xref ref-type="bibr" rid="B95">95</xref>) studies. Deficiency of thiamine is implicated in depressive symptoms in older adults (<xref ref-type="bibr" rid="B96">96</xref>). Microbial production results in a pool of free, absorbable thiamine and, similarly to folate, specific carrier proteins exist to transport free thiamine into both intestinal enterocytes and colonocytes (<xref ref-type="bibr" rid="B97">97</xref>). Microbial production of vitamins also may affect humans indirectly in a kind of food chain where vitamins produced by certain microbes are needed by other microbiota whose downstream products impact depression. For example, about half of human gut microbes are thiamine auxotrophs, i.e., they require but cannot make their own thiamine (<xref ref-type="bibr" rid="B98">98</xref>).</p>
</sec>
<sec>
<title>Inflammatory Regulation</title>
<p>Depression and anxiety symptoms increase with functional gut disorders (<xref ref-type="bibr" rid="B99">99</xref>). Irritable bowel syndrome (IBS) has been characterized by increased permeability of the mucosal layer (<xref ref-type="bibr" rid="B100">100</xref>, <xref ref-type="bibr" rid="B101">101</xref>) as well as gut microbiome dysbiosis (<xref ref-type="bibr" rid="B102">102</xref>). Inflammation can compromise normal barriers protecting the body from pathogenic gut bacteria (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B103">103</xref>), resulting in intestinal permeability (<xref ref-type="bibr" rid="B104">104</xref>), or “leaky gut,” and even leakage at the blood-brain barrier (<xref ref-type="bibr" rid="B105">105</xref>, <xref ref-type="bibr" rid="B106">106</xref>). One mechanism whereby this occurs is tumor necrosis factor alpha (TNFα) induction of shedding and apopotosis of intestinal epithelial cells (<xref ref-type="bibr" rid="B107">107</xref>). This has been suggested as an explanation for the high association of inflammatory gastrointestinal disorders with depression; for example, 49% of people with inflammatory bowel disease suffer from depressive symptoms (<xref ref-type="bibr" rid="B89">89</xref>). Gut dysbiosis promotion of inflammation may contribute to multiple pathways in the CNS that are implicated in the development of depression. Upregulation of inflammatory cytokines (<xref ref-type="bibr" rid="B108">108</xref>) has downstream consequences in brain, including shunting of tryptophan away from serotonin synthesis toward the kynurenine pathway (<xref ref-type="bibr" rid="B109">109</xref>) as well as excitotoxic and neurotoxic effects (<xref ref-type="bibr" rid="B110">110</xref>, <xref ref-type="bibr" rid="B111">111</xref>).</p>
</sec>
<sec>
<title>Production of Neurotransmitters</title>
<p>In cell culture studies, gut microbiota have been found to make precursers to neurotransmitters, such as tryptamine (<xref ref-type="bibr" rid="B112">112</xref>), and neurotransmitters including GABA (<xref ref-type="bibr" rid="B9">9</xref>), serotonin, norepinephrine, and dopamine (<xref ref-type="bibr" rid="B57">57</xref>). Among the bacteria found in the reviewed studies to be lower in MDD (<xref ref-type="bibr" rid="B28">28</xref>), <italic>Bifidobacterium</italic> is an efficient producer of GABA (<xref ref-type="bibr" rid="B113">113</xref>). Several bacterial strains are known to produce serotonin directly (<xref ref-type="bibr" rid="B114">114</xref>). Moreover, one study reported that male rodents reared in a germ-free environment, a profound manipulation of the microbiome, exhibit increased levels of serotonin in the hippocampus, along with increased peripheral levels of tryptophan, a serotonin precursor, suggesting the possibility of a peripheral origin to this effect (<xref ref-type="bibr" rid="B21">21</xref>). Another animal study found that administration of a probiotic containing <italic>Lactobacillus plantarum</italic> PS128 led to both antidepressant-like effects in mice as well as increases in levels of serotonin and dopamine in the striatum (<xref ref-type="bibr" rid="B115">115</xref>). Modulation of neurotransmitter production is one possible means by which the gut microbiome may affect the brain, with direct relevance to depression.</p>
</sec>
</sec>
<sec>
<title>Human Brain Imaging Supporting Gut Microbiome-Brain Communication</title>
<p>The current literature supports bidirectional interactions between the gut and brain mediated by gut microbiota (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B116">116</xref>, <xref ref-type="bibr" rid="B117">117</xref>). There is evidence that gut microbiome composition is correlated with neural activity and brain structure in humans, as assessed by functional and structural MRI (<xref ref-type="bibr" rid="B118">118</xref>, <xref ref-type="bibr" rid="B119">119</xref>). Specificially, an observational study in obese and non-obese individuals found that both microbial diversity as well as relative abundance of <italic>Actinobacteria</italic> were associated with measures of white matter integrity and of regional iron content in the brain (<xref ref-type="bibr" rid="B118">118</xref>). Another study in healthy female volunteers identified two clusters of individuals based on bacterial genotyping, a <italic>Bacteroides</italic>-abundant group and a <italic>Prevotella</italic>-abundant group, and observed differences in measures of both structural and functional neuroimaging when comparing these groups (<xref ref-type="bibr" rid="B119">119</xref>). Both <italic>Bacteroides</italic> (<xref ref-type="bibr" rid="B27">27</xref>) and <italic>Prevotella</italic> (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B29">29</xref>) were associated with MDD in specific case-control studies and exhibited divergent directionality.</p>
<p>Moreover, probiotic interventions can alter neural responses assessed by fMRI (<xref ref-type="bibr" rid="B120">120</xref>, <xref ref-type="bibr" rid="B121">121</xref>). Specifically, randomized, double-blind, placebo-controlled treatment with <italic>Bifidobacterium longum</italic> in patients with irritable bowel syndrome led to reduction in neural responses to emotionally negative stimuli in limbic brain regions including the amygdala (<xref ref-type="bibr" rid="B121">121</xref>). Likewise, <italic>B. longum</italic> administration to mice via oral gavage had an anxiolytic effect, and this was not seen in vagotomized animals (<xref ref-type="bibr" rid="B116">116</xref>). Another small randomized trial in healthy women found that administration of a probiotic containing multiple species was associated with a decrease in neural responses to an emotional faces attention task in a broad network of brain regions, including insula and somatosensory processing regions (<xref ref-type="bibr" rid="B120">120</xref>). In rodents, oral gavage administration of <italic>Lactobacillus rhamnosus</italic>, which improved anxiety- and depression-like behaviors, also caused brain region-specific alterations in GABA<sub>Aα2</sub> mRNA expression detected by <italic>in situ</italic> hybridization (<xref ref-type="bibr" rid="B117">117</xref>). Neither the neurochemical nor the behavioral effects were seen in vagotomized animals, indicating that the vagus nerve mediated this particular communication between the gut microbiota and brain.</p>
<p>Important features of gut-brain communication that require further elucidation with respect to influences in MDD include the different roles of luminal vs. systemic bacteria, the mechanisms of traversing the gut barrier into the portal circulation and the blood-brain barrier (BBB), and the role of the vagus nerve.</p>
</sec>
<sec>
<title>The Role of Diet</title>
<p>Dietary effects on the gut microbiome are evident as early as infancy, with gut microbiome differences observed between breast-fed and formula-fed infants, including a greater prevalence of <italic>Bifidobacteria</italic> in breast-fed infants (<xref ref-type="bibr" rid="B122">122</xref>). In adulthood, gut microbiome composition is associated with self-reported long-term dietary patterns, with a higher prevalence of <italic>Prevotella</italic> observed in individuals reporting higher intake of carbohydrates and simple sugars, and a higher prevalence of <italic>Bacteroides</italic> observed in individuals reporting higher intake of animal protein and saturated fats (<xref ref-type="bibr" rid="B32">32</xref>). Effects of short-term dietary interventions on the gut microbiome are not well understood. As one example, probiotic administration in a recent study led not only to changes in brain activity assessed by fMRI (see section Human Brain Imaging Supporting Gut Microbiome-Brain Communication above), but also to antidepressant effects and changes in urine metabolic profiles, suggestive of microbiome effects, but no measureable effects on gut microbiome composition were detected by fecal 16S rRNA gene sequencing (<xref ref-type="bibr" rid="B121">121</xref>). It is unclear to what extent this finding reflects limitations in our current microbiome quantification tools, or resistance of the gut microbiome to change.</p>
<p>One dietary factor in the microbiome-inflammation-depression relationship is the intake of polyunsaturated fatty acids (PUFAs), especially with regard to the ratio of omega-3 to omega-6 PUFAs, which has been found to be low in depression (<xref ref-type="bibr" rid="B123">123</xref>). Omega-3 PUFAs tend to be anti-inflammatory while omega-6 PUFAs such as arachidonic acid tend to be pro-inflammatory [reviewed in (<xref ref-type="bibr" rid="B124">124</xref>)], and the PUFA balance has effects on mucus adhesion of bacteria (<xref ref-type="bibr" rid="B125">125</xref>). For example, in a study of gnotobiotic piglets the growth and mucus adhesion of probiotic <italic>Lactobacillus paracasei</italic> were enhanced by concomitant administration of a mixture of PUFAs (<xref ref-type="bibr" rid="B126">126</xref>). Omega-6 PUFAs also are implicated in epithelial permeability and mucosal damage through the generation of leukotrienes, inflammatory metabolites of arachidonic acid (<xref ref-type="bibr" rid="B127">127</xref>). Dietary PUFA serves as a substrate for some gut microbes, and PUFA-derived metabolites have been proposed as novel gut microbial products that may have important physiological effects (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B128">128</xref>). Among the genera reported in the reviewed case-control studies as less abundant in MDD, <italic>Bifidobacterium</italic> degrades unsaturated fatty acids including linoleic acid (<xref ref-type="bibr" rid="B129">129</xref>), a precursor to arachidonic acid.</p>
</sec>
<sec>
<title>Current Analytic Tools</title>
<p>The analysis of trillions of gut microorganisms with respect to genomic composition and functionality, which includes a complex ecological network of interactions among bacteria and with the host, is truly a “big data” enterprise. Increasingly sophisticated systems biology techniques are coming on line to perform these analyses, among them genome-scale metabolic modeling (GEM), which aims to comprehensively describe the metabolism of a microbe or a microbial community (<xref ref-type="bibr" rid="B130">130</xref>). These systems were conceptualized 30 years ago and are now reaching the stage of development where they can begin to be utilized for predictive biology approaches (<xref ref-type="bibr" rid="B131">131</xref>). For example, the GEM for <italic>Escherichia coli</italic> utilizes existing information of 66% of its genome and has enabled a wide variety of applications including models for interspecies metabolite exchange (<xref ref-type="bibr" rid="B132">132</xref>). Relatively new analysis methods include shotgun metagenomic sequencing, a powerful approach from which coding sequences can be annotated with respect to known metabolic pathways, allowing for functional inferences. However, this method also has drawbacks, including expense, biased representation of genome catalogs and functional annotations, sequencing of dead cells, distortions of relative abundance reporting, and minimal success in regard to mucosal microbiota (<xref ref-type="bibr" rid="B133">133</xref>). Another approach utilizes PICRUSt (Phylogenetic Investigation of Communities by Reconstruction of Unobserved States), a bioinformatic tool that allows for estimating the functional gene profile of a metagenome using marker gene data (i.e., 16S sequences) and a set of known genomes. This tool applies an ancestral state reconstruction algorithm that predicts the presence of gene families and then combines these into a metagenome. As such it provides a predictive metagenome and offers insights into functional capacities of uncultured bacterial communities. Other novel indices may also have greater merit for distinguishing between affected and unaffected populations than abundance or diversity measurements. For example, the growth rate of the bacterial population, assessed as the ratio of DNA copy number of DNA regions near the replication origin to those near the terminus, has been shown to correlate with illness better than species abundance in inflammatory bowel disease and type II diabetes (<xref ref-type="bibr" rid="B134">134</xref>).</p>
</sec>
<sec>
<title>Developing Standards for Future Studies</title>
<p>Major sources of controllable clinical heterogeneity identified in this review that can affect quantitative comparability of clinical trials include: (<xref ref-type="bibr" rid="B1">1</xref>) psychiatric medication status; (<xref ref-type="bibr" rid="B2">2</xref>) type of comparison group; (<xref ref-type="bibr" rid="B3">3</xref>) medical comorbidities; (<xref ref-type="bibr" rid="B4">4</xref>) non-antibiotic medications impacting the gut microbiome (<xref ref-type="bibr" rid="B135">135</xref>); (<xref ref-type="bibr" rid="B5">5</xref>) psychiatric comorbidities including substance use disorders; and (<xref ref-type="bibr" rid="B6">6</xref>) use of well-validated diagnostic and depression severity assessment instruments.</p>
<p>Although bioinformatic analysis pipelines in general are well-standardized, handling of specimens, DNA extraction protocols and sequencing methods introduce another important type of heterogeneity.</p>
<p>Geographic differences may have a profound impact on study outcomes (<xref ref-type="bibr" rid="B32">32</xref>–<xref ref-type="bibr" rid="B34">34</xref>), reflecting differences in ethnicity, environmental exposures, or diet. Attempts to control statistically for location found interpolation to be more successful than an extrapolative approach (<xref ref-type="bibr" rid="B34">34</xref>).</p>
<p>The use of a standard panel of covariates would be an essential approach to reduce the “noise” within which the depression signal will need to be detected. Standards should include assessment of diet, although this is difficult to achieve comprehensively. One aspect of diet that may be important to quantify with respect to depression includes consumption of wine, a major source of polyphenols that interact with the microbiome resulting in decreased fecal concentrations of inflammatory cytokines (<xref ref-type="bibr" rid="B136">136</xref>). Easily quantified non-dietary information that has a robust effect size on the gut microbiome has been reported in studies (<xref ref-type="bibr" rid="B137">137</xref>, <xref ref-type="bibr" rid="B138">138</xref>) using data from the Belgian Flemish Gut Flora Project (FGFP; <italic>N</italic> = 1,106) and the Dutch LifeLines-DEEP study (LLDeep; <italic>N</italic> = 1,135), as well a larger study from China (<italic>N</italic> = 7,009) (<xref ref-type="bibr" rid="B34">34</xref>). Considering non-dietary covariates, all three studies found Bristol stool score, age, sex, body-mass index, triglycerides, cholesterol, and smoking status to be among the characteristics most strongly associated with microbiome composition.</p>
<p>This demonstrated need to build statistical models that control for multiple covariates mandates larger sample sizes. Without more studies, effect sizes for depression association with the microbiome are presently uncertain. However, several approaches may increase power to detect a role of dysbiosis in mood disorders. One strategy is to recruit individuals with extreme illness phenotypes. This has been used successfully in psychiatric (<xref ref-type="bibr" rid="B139">139</xref>) and non-psychiatric (<xref ref-type="bibr" rid="B140">140</xref>) medical research to elucidate pathophysiology. Applying this principle to the case of mood disorders, studies of individuals with recurrent depressive episodes, history of suicidality, or current inpatient treatment may represent a more extreme phenotype with greater likelihood of demonstrating biological abnormalities including dysbiosis. Given the significant clinical and biological heterogeneity of depression, focusing on a more narrow, severe phenotype may increase statistical power in microbiome studies (<xref ref-type="bibr" rid="B141">141</xref>).</p>
<p>Case-control designs are limited by the potential for confounding factors between patient and control groups. Aspects of study design that may further increase power of future microbiome studies of depression include dense clinical phenotyping of depression severity and symptom profiles using well-validated assessment tools including the HAM (<xref ref-type="bibr" rid="B142">142</xref>) and the Beck Depression Inventory (<xref ref-type="bibr" rid="B143">143</xref>). This would allow for within-group correlation analyses, as well as longitudinal microbiome quantification within patient groups, harnessing the statistical power of within-subject statistical designs to examine questions of state vs. trait abnormalities.</p>
<p>Thus, ideal study conditions would feature a large sample of more severely ill, unmedicated patients diagnosed with MDD and assessed for severity by trained clinical researchers using validated instruments, in comparison to comprehensively assessed healthy volunteers matched for sex, age, race, and geographic/ethnic background. Subjects with current substance use disorders or active medical illness, including chronic inflammatory conditions, would be excluded from both MDD and psychiatrically healthy volunteer groups. Comprehensive diagnostic information obtained would include details on past substance use history. Subjects would complete dietary assessments, such as the USFDA's Healthy Eating Index (<xref ref-type="bibr" rid="B144">144</xref>), which has been validated for studying the microbiome (<xref ref-type="bibr" rid="B145">145</xref>), and this information plus data on Bristol stool score, body-mass index, triglycerides, cholesterol, and smoking status would be included as covariates in statistical modeling. Interpretation of the results would need to include rigorous control for false discovery rates.</p>
<p>Similar to the situation with depression, the study of the microbiome across a range of other neuropsychiatric conditions is in its infancy (<xref ref-type="bibr" rid="B146">146</xref>), e.g., reviews of human research on dysbiosis report on only 12 articles concerning autism (<xref ref-type="bibr" rid="B147">147</xref>) and five articles concerning schizophrenia and bipolar disorder combined (<xref ref-type="bibr" rid="B148">148</xref>). When greater consensus is reached regarding the nature of dysbiosis in individual neuropsychiatric conditions, perhaps by employing techniques advocated here for standardization and sample selection, an important question will be to determine the degree of overlap in findings across these conditions. The use of an open science approach, creating data sharing and data repositories specific to psychiatric illness, will be important to advancing the field of what may be called the psychomicrobiome. Such an approach would facilitate amassing sample sizes that are sufficiently powered to detect the effects of the confounding variables described above and to detect what may be modest effect sizes in primary contrasts of interest.</p>
</sec>
<sec>
<title>Limitations</title>
<p>Our review of this literature is limited to a descriptive approach. Because these studies were disparate in their aims and methodologies, studied heterogeneous populations, reported on relative rather than absolute abundance, and were small and likely underpowered, a meta-analytic approach would be handicapped.</p>
<p>The search for gut microbiota via stool carries specific limitations. Location of the taxa within the gut may be an important determinant of microbial effects on the host organism (<xref ref-type="bibr" rid="B46">46</xref>), but stool may represent luminal and lower intestinal populations, and composition differs between upper and lower intestine and between luminal and mucosal layers (<xref ref-type="bibr" rid="B149">149</xref>). Additionally, it may not be clear whether a taxon maintains a stable population within the host (autochthonous) or is just passing through (allochthonous); feces may consist of allochthonous taxa plus some particularly proliferative and not so adherent authochthonous taxa (<xref ref-type="bibr" rid="B6">6</xref>). We further note that other sites of the human microbiome may be equally or more relevant but are understudied with regard to depression, e.g., the oral cavity [already used in human studies of anxiety (<xref ref-type="bibr" rid="B150">150</xref>), stress (<xref ref-type="bibr" rid="B151">151</xref>), autism spectrum disorders (<xref ref-type="bibr" rid="B152">152</xref>), and migraine (<xref ref-type="bibr" rid="B153">153</xref>)], which can be easily and directly sampled.</p>
</sec>
</sec>
<sec id="s5" sec-type="conclusions">
<title>Conclusions</title>
<p>The limited existing human studies of depression and gut microbiota report depression-specific findings regarding proportions of microbiota; however, the sample sizes are small, and no consensus has emerged concerning which bacterial taxa are most relevant to depression. Therefore, the effect size of depression-related microbial differences is presently unclear. Future, larger studies may employ a functional system of categorization, and should evaluate BMI, presence of inflammation, and diet, and control for other factors that may be important covariates. Studying depressed patients who are unmedicated at the time of microbiome assessment and in an active depressed state may help address possible confounds of antidepressant medication effects and state vs. trait effects. Improved resolution at the species level may be achieved using next-generation sequencing approaches. Given the evidence of microbial function that transcends taxonomic classification, and the ecological nature of the microbial community, approaches such as bacterial growth rate and genome-scale metabolic modeling may prove useful in better understanding the contribution of the gut microbiome to depression etiology.</p>
</sec>
<sec>
<title>Author Contributions</title>
<p>JMM, MES, AG, and SC conceptualized the project. AG and SC performed the literature review. SC wrote the first draft of the manuscript. JJM and A-CU critically reviewed the manuscript with respect to their areas of expertise: depression (JJM) and gut microbiology (A-CU). All authors contributed to writing and revising the manuscript.</p>
<sec>
<title>Conflict of Interest Statement</title>
<p>JJM receives royalties for the commercial use of the C-SSRS from the Research Foundation for Mental Hygiene. A-CU received research funding from Allergan and GSK unrelated to the current study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This study was supported by the following grants: R01 AI116939 (A-CU), P50 MH090964 (JJM), Nathaniel Wharton Fund Pilot Award (SC).</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gotlib</surname><given-names>IH</given-names></name><name><surname>Hammen</surname><given-names>CL</given-names></name></person-group>
<source/>Handbook of Depression. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>The Guilford Press</publisher-name> (<year>2009</year>).</mixed-citation>
</ref>
<ref id="B2">
<label>2.</label>
<mixed-citation publication-type="book"><person-group person-group-type="author"><collab>WHO</collab></person-group>
<source/>Depression and Other Common Mental Disorders: Global Health Estimates. <publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name> (<year>2017</year>). p. <fpage>1</fpage>–<lpage>24</lpage>.</mixed-citation>
</ref>
<ref id="B3">
<label>3.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>WHO</collab></person-group>
<source/>Depression Fact Sheet. WHO (<year>2017</year>).</mixed-citation>
</ref>
<ref id="B4">
<label>4.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dean</surname><given-names>J</given-names></name><name><surname>Keshavan</surname><given-names>M</given-names></name></person-group>. <article-title>The neurobiology of depression: an integrated view</article-title>. <source/>Asian J Psychiatry (<year>2017</year>) <volume>27</volume>:<fpage>101</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajp.2017.01.025</pub-id><pub-id pub-id-type="pmid">28558878</pub-id></mixed-citation>
</ref>
<ref id="B5">
<label>5.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lederberg</surname><given-names>J</given-names></name><name><surname>McCray</surname><given-names>JE</given-names></name></person-group>
<article-title>“Ome sweet” omics: a genealogical treasury of words</article-title>. <source/>TheScientist (<year>2001</year>) <volume>15</volume>:<fpage>8</fpage>.</mixed-citation>
</ref>
<ref id="B6">
<label>6.</label>
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Tannock</surname><given-names>GW</given-names></name></person-group>
<source/>Understanding the Gut Microbiota.
<publisher-loc>Hoboken, NJ</publisher-loc>: <publisher-name>John Wiley &amp; Sons</publisher-name> (<year>2017</year>). <pub-id pub-id-type="doi">10.1002/9781118801413</pub-id></mixed-citation>
</ref>
<ref id="B7">
<label>7.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hara</surname><given-names>AM</given-names></name><name><surname>Shanahan</surname><given-names>F</given-names></name></person-group>
<article-title>The gut flora as a forgotten organ</article-title>. <source/>EMBO Rep. (<year>2006</year>) <volume>7</volume>:<fpage>688</fpage>
<pub-id pub-id-type="doi">10.1038/sj.embor.7400731</pub-id><pub-id pub-id-type="pmid">16819463</pub-id></mixed-citation>
</ref>
<ref id="B8">
<label>8.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ait-Belgnaoui</surname><given-names>A</given-names></name><name><surname>Durand</surname><given-names>H</given-names></name><name><surname>Cartier</surname><given-names>C</given-names></name><name><surname>Chaumaz</surname><given-names>G</given-names></name><name><surname>Eutamene</surname><given-names>H</given-names></name><name><surname>Ferrier</surname><given-names>L</given-names></name><etal></etal></person-group>. <article-title>Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats</article-title>. <source/>Psychoneuroendocrinology (<year>2012</year>) <volume>37</volume>:<fpage>1885</fpage>–<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1016/j.psyneuen.2012.03.024</pub-id><pub-id pub-id-type="pmid">22541937</pub-id></mixed-citation>
</ref>
<ref id="B9">
<label>9.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>E</given-names></name><name><surname>Ross</surname><given-names>RP</given-names></name><name><surname>O'Toole</surname><given-names>PW</given-names></name><name><surname>Fitzgerald</surname><given-names>GF</given-names></name><name><surname>Stanton</surname><given-names>C</given-names></name></person-group>. <article-title>γ-Aminobutyric acid production by culturable bacteria from the human intestine</article-title>. <source/>J Appl Microbiol. (<year>2012</year>) <volume>113</volume>:<fpage>411</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2672.2012.05344.x</pub-id><pub-id pub-id-type="pmid">22612585</pub-id></mixed-citation>
</ref>
<ref id="B10">
<label>10.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cummings</surname><given-names>JH</given-names></name><name><surname>Pomare</surname><given-names>EW</given-names></name><name><surname>Branch</surname><given-names>WJ</given-names></name><name><surname>Naylor</surname><given-names>CP</given-names></name><name><surname>Macfarlane</surname><given-names>GT</given-names></name></person-group>. <article-title>Short chain fatty acids in human large intestine, portal, hepatic and venous blood</article-title>. <source/>Gut (<year>1987</year>) <volume>28</volume>:<fpage>1221</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1136/gut.28.10.1221</pub-id><pub-id pub-id-type="pmid">3678950</pub-id></mixed-citation>
</ref>
<ref id="B11">
<label>11.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hooper</surname><given-names>LV</given-names></name><name><surname>Stappenbeck</surname><given-names>TS</given-names></name><name><surname>Hong</surname><given-names>CV</given-names></name><name><surname>Gordon</surname><given-names>JI</given-names></name></person-group>. <article-title>Angiogenins: a new class of microbicidal proteins involved in innate immunity</article-title>. <source/>Nat Immunol. (<year>2003</year>) <volume>4</volume>:<fpage>269</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1038/ni888</pub-id><pub-id pub-id-type="pmid">12548285</pub-id></mixed-citation>
</ref>
<ref id="B12">
<label>12.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schauber</surname><given-names>J</given-names></name><name><surname>Svanholm</surname><given-names>C</given-names></name><name><surname>Termén</surname><given-names>S</given-names></name><name><surname>Iffland</surname><given-names>K</given-names></name><name><surname>Menzel</surname><given-names>T</given-names></name><name><surname>Scheppach</surname><given-names>W</given-names></name><etal></etal></person-group>. <article-title>Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways</article-title>. <source/>Gut (<year>2003</year>) <volume>52</volume>:<fpage>735</fpage>–<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1136/gut.52.5.735</pub-id><pub-id pub-id-type="pmid">12692061</pub-id></mixed-citation>
</ref>
<ref id="B13">
<label>13.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cash</surname><given-names>HL</given-names></name><name><surname>Whitham</surname><given-names>CV</given-names></name><name><surname>Behrendt</surname><given-names>CL</given-names></name><name><surname>Hooper</surname><given-names>LV</given-names></name></person-group>. <article-title>Symbiotic bacteria direct expression of an intestinal bactericidal lectin</article-title>. <source/>Science (<year>2006</year>) <volume>313</volume>:<fpage>1126</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1126/science.1127119</pub-id><pub-id pub-id-type="pmid">16931762</pub-id></mixed-citation>
</ref>
<ref id="B14">
<label>14.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouskra</surname><given-names>D</given-names></name><name><surname>Brézillon</surname><given-names>C</given-names></name><name><surname>Bérard</surname><given-names>M</given-names></name><name><surname>Werts</surname><given-names>C</given-names></name><name><surname>Varona</surname><given-names>R</given-names></name><name><surname>Boneca</surname><given-names>IG</given-names></name><etal></etal></person-group>. <article-title>Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis</article-title>. <source/>Nature (<year>2008</year>) <volume>456</volume>:<fpage>507</fpage>. <pub-id pub-id-type="doi">10.1038/nature07450</pub-id><pub-id pub-id-type="pmid">18987631</pub-id></mixed-citation>
</ref>
<ref id="B15">
<label>15.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>PM</given-names></name><name><surname>Howitt</surname><given-names>MR</given-names></name><name><surname>Panikov</surname><given-names>N</given-names></name><name><surname>Michaud</surname><given-names>M</given-names></name><name><surname>Gallini</surname><given-names>CA</given-names></name><name><surname>Bohlooly</surname><given-names>YM</given-names></name><etal></etal></person-group>. <article-title>The microbial metabolites, short chain fatty acids, regulate colonic Treg cell homeostasis</article-title>. <source/>Science (<year>2013</year>) <volume>341</volume>:<fpage>569</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1126/science.1241165.</pub-id><pub-id pub-id-type="pmid">23828891</pub-id></mixed-citation>
</ref>
<ref id="B16">
<label>16.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyamoto</surname><given-names>J</given-names></name><name><surname>Mizukure</surname><given-names>T</given-names></name><name><surname>Park</surname><given-names>SB</given-names></name><name><surname>Kishino</surname><given-names>S</given-names></name><name><surname>Kimura</surname><given-names>I</given-names></name><name><surname>Hirano</surname><given-names>K</given-names></name><etal></etal></person-group>. <article-title>A gut microbial metabolite of linoleic acid, 10-hydroxy-cis-12-octadecenoic acid, ameliorates intestinal epithelial barrier impairment partially via GPR40-MEK-ERK pathway</article-title>. <source/>J Biol Chem. (<year>2015</year>) <volume>290</volume>:<fpage>2902</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M114.610733</pub-id><pub-id pub-id-type="pmid">25505251</pub-id></mixed-citation>
</ref>
<ref id="B17">
<label>17.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maes</surname><given-names>M</given-names></name><name><surname>Kubera</surname><given-names>M</given-names></name><name><surname>Leunis</surname><given-names>JC</given-names></name></person-group>. <article-title>The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria, (leaky gut) plays a role in the inflammatory pathophysiology of depression</article-title>. <source/>Neuro Endocrinol Lett. (<year>2008</year>) <volume>29</volume>:<fpage>117</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="pmid">18283240</pub-id></mixed-citation>
</ref>
<ref id="B18">
<label>18.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maes</surname><given-names>M</given-names></name><name><surname>Kubera</surname><given-names>M</given-names></name><name><surname>Leunis</surname><given-names>JC</given-names></name><name><surname>Berk</surname><given-names>M</given-names></name></person-group>
<article-title>Increased IgA and IgM responses against gut commensals in chronic depression: further evidence for increased bacterial translocation or leaky gut</article-title>. <source/>J Affect Disord. (<year>2012</year>) <volume>141</volume>:<fpage>55</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1016/j.jad.2012.02.023</pub-id><pub-id pub-id-type="pmid">22410503</pub-id></mixed-citation>
</ref>
<ref id="B19">
<label>19.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maes</surname><given-names>M</given-names></name><name><surname>Kubera</surname><given-names>M</given-names></name><name><surname>Leunis</surname><given-names>JC</given-names></name><name><surname>Berk</surname><given-names>M</given-names></name><name><surname>Geffard</surname><given-names>M</given-names></name><name><surname>Bosmans</surname><given-names>E</given-names></name></person-group>. <article-title>In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress, (O&amp;NS), and autoimmune responses directed against O&amp;NS-damaged neoepitopes</article-title>. <source/>Acta Psychiatr Scand. (<year>2013</year>) <volume>127</volume>:<fpage>344</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0447.2012.01908.x</pub-id><pub-id pub-id-type="pmid">22900942</pub-id></mixed-citation>
</ref>
<ref id="B20">
<label>20.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guida</surname><given-names>F</given-names></name><name><surname>Turco</surname><given-names>F</given-names></name><name><surname>Iannotta</surname><given-names>M</given-names></name><name><surname>De Gregorio</surname><given-names>D</given-names></name><name><surname>Palumbo</surname><given-names>I</given-names></name><name><surname>Sarnelli</surname><given-names>G</given-names></name><etal></etal></person-group>. <article-title>Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes, hippocampal neuroglial reorganization and depression in mice</article-title>. <source/>Brain Behav Immun. (<year>2018</year>) <volume>67</volume>:<fpage>230</fpage>–<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2017.09.001</pub-id><pub-id pub-id-type="pmid">28890155</pub-id></mixed-citation>
</ref>
<ref id="B21">
<label>21.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clarke</surname><given-names>G</given-names></name><name><surname>Grenham</surname><given-names>S</given-names></name><name><surname>Scully</surname><given-names>P</given-names></name><name><surname>Fitzgerald</surname><given-names>P</given-names></name><name><surname>Moloney</surname><given-names>RD</given-names></name><name><surname>Shanahan</surname><given-names>F</given-names></name><etal></etal></person-group>. <article-title>The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner</article-title>. <source/>Mol Psychiatry (<year>2013</year>) <volume>18</volume>:<fpage>666</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2012.77</pub-id><pub-id pub-id-type="pmid">22688187</pub-id></mixed-citation>
</ref>
<ref id="B22">
<label>22.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>JR</given-names></name><name><surname>Borre</surname><given-names>Y</given-names></name><name><surname>O'Brien</surname><given-names>C</given-names></name><name><surname>Patterson</surname><given-names>E</given-names></name><name><surname>El Aidy</surname><given-names>S</given-names></name><name><surname>Deane</surname><given-names>J</given-names></name><etal></etal></person-group>. <article-title>Transferring the blues: depression-associated gut microbiota induces neurobehavioural changes in the rat</article-title>. <source/>J Psychiatr Res. (<year>2016</year>) <volume>82</volume>:<fpage>109</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpsychires.2016.07.019</pub-id><pub-id pub-id-type="pmid">27491067</pub-id></mixed-citation>
</ref>
<ref id="B23">
<label>23.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>P</given-names></name><name><surname>Zeng</surname><given-names>B</given-names></name><name><surname>Zhou</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Fang</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><etal></etal></person-group>. <article-title>Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism</article-title>. <source/>Mol Psychiatry (<year>2016</year>) <volume>21</volume>:<fpage>786</fpage>–<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2016.44</pub-id><pub-id pub-id-type="pmid">27067014</pub-id></mixed-citation>
</ref>
<ref id="B24">
<label>24.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mi</surname><given-names>GL</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Qiao</surname><given-names>DD</given-names></name><name><surname>Kang</surname><given-names>WQ</given-names></name><name><surname>Tang</surname><given-names>MQ</given-names></name><name><surname>Xu</surname><given-names>JK</given-names></name></person-group>. <article-title>Effectiveness of Lactobacillus reuteri in infantile colic and colicky induced maternal depression: a prospective single blind randomized trial</article-title>. <source/>Antonie van Leeuwenhoek (<year>2015</year>) <volume>107</volume>:<fpage>1547</fpage>–<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1007/s10482-015-0448-9</pub-id><pub-id pub-id-type="pmid">25876529</pub-id></mixed-citation>
</ref>
<ref id="B25">
<label>25.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsiao</surname><given-names>EY</given-names></name><name><surname>Sara McBride</surname><given-names>W</given-names></name><name><surname>Hsien</surname><given-names>S</given-names></name><name><surname>Sharon</surname><given-names>G</given-names></name><name><surname>Embriette Hyde</surname><given-names>R</given-names></name><name><surname>McCue</surname><given-names>T</given-names></name><etal></etal></person-group>. <article-title>Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders</article-title>. <source/>Cell (<year>2013</year>) <volume>155</volume>:<fpage>1451</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2013.11.024</pub-id><pub-id pub-id-type="pmid">24315484</pub-id></mixed-citation>
</ref>
<ref id="B26">
<label>26.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naseribafrouei</surname><given-names>A</given-names></name><name><surname>Hestad</surname><given-names>K</given-names></name><name><surname>Avershina</surname><given-names>E</given-names></name><name><surname>Sekelja</surname><given-names>M</given-names></name><name><surname>Linlokken</surname><given-names>A</given-names></name><name><surname>Wilson</surname><given-names>R</given-names></name><etal></etal></person-group>. <article-title>Correlation between the human fecal microbiota and depression</article-title>. <source/>Neurogastroenterol Motil (<year>2014</year>) <volume>26</volume>:<fpage>1155</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1111/nmo.12378</pub-id><pub-id pub-id-type="pmid">24888394</pub-id></mixed-citation>
</ref>
<ref id="B27">
<label>27.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>H</given-names></name><name><surname>Ling</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Mao</surname><given-names>H</given-names></name><name><surname>Ma</surname><given-names>Z</given-names></name><name><surname>Yin</surname><given-names>Y</given-names></name><etal></etal></person-group>. <article-title>Altered fecal microbiota composition in patients with major depressive disorder</article-title>. <source/>Brain Behav Immun. (<year>2015</year>) <volume>48</volume>:<fpage>186</fpage>–<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2015.03.016</pub-id><pub-id pub-id-type="pmid">25882912</pub-id></mixed-citation>
</ref>
<ref id="B28">
<label>28.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aizawa</surname><given-names>E</given-names></name><name><surname>Tsuji</surname><given-names>H</given-names></name><name><surname>Asahara</surname><given-names>T</given-names></name><name><surname>Takahashi</surname><given-names>T</given-names></name><name><surname>Teraishi</surname><given-names>T</given-names></name><name><surname>Yoshida</surname><given-names>S</given-names></name><etal></etal></person-group>. <article-title>Possible association of Bifidobacterium and Lactobacillus in the gut microbiota of patients with major depressive disorder</article-title>. <source/>J Affect Disord. (<year>2016</year>) <volume>202</volume>:<fpage>254</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.jad.2016.05.038</pub-id><pub-id pub-id-type="pmid">27288567</pub-id></mixed-citation>
</ref>
<ref id="B29">
<label>29.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>P</given-names></name><name><surname>Ding</surname><given-names>B</given-names></name><name><surname>Feng</surname><given-names>C</given-names></name><name><surname>Yin</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Qi</surname><given-names>X</given-names></name><etal></etal></person-group>. <article-title>Prevotella and Klebsiella proportions in fecal microbial communities are potential characteristic parameters for patients with major depressive disorder</article-title>. <source/>J Affect Disord. (<year>2017</year>) <volume>207</volume>:<fpage>300</fpage>–<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1016/j.jad.2016.09.051</pub-id><pub-id pub-id-type="pmid">27741466</pub-id></mixed-citation>
</ref>
<ref id="B30">
<label>30.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Gui</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>C</given-names></name><etal></etal></person-group>. <article-title>Comparative metaproteomics analysis shows altered fecal microbiota signatures in patients with major depressive disorder</article-title>. <source/>Neuroreport (<year>2018</year>) <volume>29</volume>:<fpage>417</fpage>–<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1097/WNR.0000000000000985</pub-id><pub-id pub-id-type="pmid">29432299</pub-id></mixed-citation>
</ref>
<ref id="B31">
<label>31.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hawinkel</surname><given-names>S</given-names></name><name><surname>Mattiello</surname><given-names>F</given-names></name><name><surname>Bijnens</surname><given-names>L</given-names></name><name><surname>Thas</surname><given-names>O</given-names></name></person-group>
<article-title>A broken promise: microbiome differential abundance methods do not control the false discovery rate</article-title>. <source/>Brief Bioinform. (<year>2017</year>) <volume>20</volume>:<fpage>210</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1093/bib/bbx104</pub-id></mixed-citation>
</ref>
<ref id="B32">
<label>32.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>GD</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Hoffmann</surname><given-names>C</given-names></name><name><surname>Bittinger</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>YY</given-names></name><name><surname>Keilbaugh</surname><given-names>SA</given-names></name><etal></etal></person-group>. <article-title>Linking long-term dietary patterns with gut microbial enterotypes</article-title>. <source/>Science (<year>2011</year>) <volume>334</volume>:<fpage>105</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1126/science.1208344</pub-id><pub-id pub-id-type="pmid">21885731</pub-id></mixed-citation>
</ref>
<ref id="B33">
<label>33.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDonald</surname><given-names>D</given-names></name><name><surname>Hyde</surname><given-names>E</given-names></name><name><surname>Debelius</surname><given-names>JW</given-names></name><name><surname>Morton</surname><given-names>JT</given-names></name><name><surname>Gonzalez</surname><given-names>A</given-names></name><name><surname>Ackermann</surname><given-names>G</given-names></name><etal></etal></person-group>. <article-title>American Gut: an open platform for citizen science microbiome research</article-title>. <source/>mSystems (<year>2018</year>) <volume>3</volume>: <fpage>e00031</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1128/mSystems.00031-18</pub-id><pub-id pub-id-type="pmid">29795809</pub-id></mixed-citation>
</ref>
<ref id="B34">
<label>34.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Zheng</surname><given-names>HM</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>McDonald</surname><given-names>D</given-names></name><name><surname>Sheng</surname><given-names>HF</given-names></name><etal></etal></person-group>
<article-title>Regional variation limits applications of healthy gut microbiome reference ranges and disease models</article-title>. <source/>Nat Med. (<year>2018</year>) <volume>24</volume>:<fpage>1532</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1038/s41591-018-0164-x</pub-id><pub-id pub-id-type="pmid">30150716</pub-id></mixed-citation>
</ref>
<ref id="B35">
<label>35.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davey</surname><given-names>KJ</given-names></name><name><surname>Cotter</surname><given-names>PD</given-names></name><name><surname>O'Sullivan</surname><given-names>O</given-names></name><name><surname>Crispie</surname><given-names>F</given-names></name><name><surname>Dinan</surname><given-names>TG</given-names></name><name><surname>Cryan</surname><given-names>JF</given-names></name><etal></etal></person-group>. <article-title>Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat</article-title>. <source/>Transl Psychiatry (<year>2013</year>) <volume>3</volume>:<fpage>e309</fpage>. <pub-id pub-id-type="doi">10.1038/tp.2013.83</pub-id><pub-id pub-id-type="pmid">24084940</pub-id></mixed-citation>
</ref>
<ref id="B36">
<label>36.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>AP</given-names></name><name><surname>Crowley</surname><given-names>JJ</given-names></name><name><surname>Nonneman</surname><given-names>RJ</given-names></name><name><surname>Quackenbush</surname><given-names>CR</given-names></name><name><surname>Miller</surname><given-names>CN</given-names></name><name><surname>Ryan</surname><given-names>AK</given-names></name><etal></etal></person-group>. <article-title>The antipsychotic olanzapine interacts with the gut microbiome to cause weight gain in mouse</article-title>. <source/>PLoS ONE (<year>2014</year>) <volume>9</volume>:<fpage>e115225</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0115225</pub-id><pub-id pub-id-type="pmid">25506936</pub-id></mixed-citation>
</ref>
<ref id="B37">
<label>37.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bahr</surname><given-names>SM</given-names></name><name><surname>Weidemann</surname><given-names>BJ</given-names></name><name><surname>Castro</surname><given-names>AN</given-names></name><name><surname>Walsh</surname><given-names>JW</given-names></name> deLeon O <name><surname>Burnett</surname><given-names>CML</given-names></name><etal></etal></person-group>. <article-title>Risperidone-induced weight gain is mediated through shifts in the gut microbiome and suppression of energy expenditure</article-title>. <source/>EBioMedicine (<year>2015</year>) <volume>2</volume>:<fpage>1725</fpage>–<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/j.ebiom.2015.10.018</pub-id><pub-id pub-id-type="pmid">28958498</pub-id></mixed-citation>
</ref>
<ref id="B38">
<label>38.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flowers</surname><given-names>SA</given-names></name><name><surname>Evans</surname><given-names>SJ</given-names></name><name><surname>Ward</surname><given-names>KM</given-names></name><name><surname>McInnis</surname><given-names>MG</given-names></name><name><surname>Ellingrod</surname><given-names>VL</given-names></name></person-group>. <article-title>Interaction between atypical antipsychotics and the gut microbiome in a bipolar disease cohort</article-title>. <source/>Pharmacotherapy (<year>2017</year>) <volume>37</volume>:<fpage>261</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1002/phar.1890</pub-id><pub-id pub-id-type="pmid">28035686</pub-id></mixed-citation>
</ref>
<ref id="B39">
<label>39.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>CM</given-names></name><name><surname>Versalovic</surname><given-names>J</given-names></name></person-group>. <article-title>Probiotics-host communication: modulation of signaling pathways in the intestine</article-title>. <source/>Gut Microbes (<year>2010</year>) <volume>1</volume>:<fpage>148</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.4161/gmic.1.3.11712</pub-id><pub-id pub-id-type="pmid">20672012</pub-id></mixed-citation>
</ref>
<ref id="B40">
<label>40.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hemarajata</surname><given-names>P</given-names></name><name><surname>Versalovic</surname><given-names>J</given-names></name></person-group>. <article-title>Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation</article-title>. <source/>Therap Adv Gastroenterol. (<year>2013</year>) <volume>6</volume>:<fpage>39</fpage>–<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1177/1756283X12459294</pub-id><pub-id pub-id-type="pmid">23320049</pub-id></mixed-citation>
</ref>
<ref id="B41">
<label>41.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Raes</surname><given-names>J</given-names></name><name><surname>Arumugam</surname><given-names>M</given-names></name><name><surname>Burgdorf</surname><given-names>KS</given-names></name><name><surname>Manichanh</surname><given-names>C</given-names></name><etal></etal></person-group>. <article-title>A human gut microbial gene catalogue established by metagenomic sequencing</article-title>. <source/>Nature (<year>2010</year>) <volume>464</volume>:<fpage>59</fpage>. <pub-id pub-id-type="doi">10.1038/nature08821</pub-id><pub-id pub-id-type="pmid">20203603</pub-id></mixed-citation>
</ref>
<ref id="B42">
<label>42.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spencer</surname><given-names>MD</given-names></name><name><surname>Hamp</surname><given-names>TJ</given-names></name><name><surname>Reid</surname><given-names>RW</given-names></name><name><surname>Fischer</surname><given-names>LM</given-names></name><name><surname>Zeisel</surname><given-names>SH</given-names></name><name><surname>Fodor</surname><given-names>AA</given-names></name></person-group>. <article-title>Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency</article-title>. <source/>Gastroenterology (<year>2011</year>) <volume>140</volume>:<fpage>976</fpage>–<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2010.11.049</pub-id><pub-id pub-id-type="pmid">21129376</pub-id></mixed-citation>
</ref>
<ref id="B43">
<label>43.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huttenhower</surname><given-names>C</given-names></name></person-group>
<article-title>Structure, function and diversity of the healthy human microbiome</article-title>. <source/>Nature (<year>2012</year>) <volume>486</volume>:<fpage>207</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1038/nature11234</pub-id><pub-id pub-id-type="pmid">22699609</pub-id></mixed-citation>
</ref>
<ref id="B44">
<label>44.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yadav</surname><given-names>M</given-names></name><name><surname>Verma</surname><given-names>MK</given-names></name><name><surname>Chauhan</surname><given-names>NS</given-names></name></person-group>. <article-title>A review of metabolic potential of human gut microbiome in human nutrition</article-title>. <source/>Arch Microbiol. (<year>2018</year>) <volume>200</volume>:<fpage>203</fpage>–<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1007/s00203-017-1459-x</pub-id><pub-id pub-id-type="pmid">29188341</pub-id></mixed-citation>
</ref>
<ref id="B45">
<label>45.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamada</surname><given-names>N</given-names></name><name><surname>Chen</surname><given-names>GY</given-names></name><name><surname>Inohara</surname><given-names>N</given-names></name><name><surname>Nunez</surname><given-names>G</given-names></name></person-group>. <article-title>Control of pathogens and pathobionts by the gut microbiota</article-title>. <source/>Nat Immunol. (<year>2013</year>) <volume>14</volume>:<fpage>685</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1038/ni.2608</pub-id><pub-id pub-id-type="pmid">23778796</pub-id></mixed-citation>
</ref>
<ref id="B46">
<label>46.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyte</surname><given-names>M</given-names></name></person-group>. <article-title>Microbial endocrinology in the microbiome-gut-brain axis: how bacterial production and utilization of neurochemicals influence behavior</article-title>. <source/>PLoS Pathogens (<year>2013</year>) <volume>9</volume>:<fpage>e1003726</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1003726</pub-id><pub-id pub-id-type="pmid">24244158</pub-id></mixed-citation>
</ref>
<ref id="B47">
<label>47.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turnbaugh</surname><given-names>PJ</given-names></name><name><surname>Hamady</surname><given-names>M</given-names></name><name><surname>Yatsunenko</surname><given-names>T</given-names></name><name><surname>Cantarel</surname><given-names>BL</given-names></name><name><surname>Duncan</surname><given-names>A</given-names></name><name><surname>Ley</surname><given-names>RE</given-names></name><etal></etal></person-group>. <article-title>A core gut microbiome in obese and lean twins</article-title>. <source/>Nature (<year>2009</year>) <volume>457</volume>:<fpage>480</fpage>–<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1038/nature07540</pub-id><pub-id pub-id-type="pmid">19043404</pub-id></mixed-citation>
</ref>
<ref id="B48">
<label>48.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haghikia</surname><given-names>A</given-names></name><name><surname>Jorg</surname><given-names>S</given-names></name><name><surname>Duscha</surname><given-names>A</given-names></name><name><surname>Berg</surname><given-names>J</given-names></name><name><surname>Manzel</surname><given-names>A</given-names></name><name><surname>Waschbisch</surname><given-names>A</given-names></name><etal></etal></person-group>. <article-title>Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine</article-title>. <source/>Immunity (<year>2015</year>) <volume>43</volume>:<fpage>817</fpage>–<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2015.09.007</pub-id><pub-id pub-id-type="pmid">26488817</pub-id></mixed-citation>
</ref>
<ref id="B49">
<label>49.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koh</surname><given-names>A</given-names></name><name><surname>De Vadder</surname><given-names>F</given-names></name><name><surname>Kovatcheva-Datchary</surname><given-names>P</given-names></name><name><surname>Backhed</surname><given-names>F</given-names></name></person-group>. <article-title>From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites</article-title>. <source/>Cell (<year>2016</year>) <volume>165</volume>:<fpage>1332</fpage>–<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2016.05.041</pub-id><pub-id pub-id-type="pmid">27259147</pub-id></mixed-citation>
</ref>
<ref id="B50">
<label>50.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimmerman</surname><given-names>MA</given-names></name><name><surname>Singh</surname><given-names>N</given-names></name><name><surname>Martin</surname><given-names>PM</given-names></name><name><surname>Thangaraju</surname><given-names>M</given-names></name><name><surname>Ganapathy</surname><given-names>V</given-names></name><name><surname>Waller</surname><given-names>JL</given-names></name><etal></etal></person-group>. <article-title>Butyrate suppresses colonic inflammation through HDAC1-dependent Fas upregulation and Fas-mediated apoptosis of T cells</article-title>. <source/>Am J Physiol. (<year>2012</year>) <volume>302</volume>:<fpage>G1405</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1152/ajpgi.00543.2011</pub-id><pub-id pub-id-type="pmid">22517765</pub-id></mixed-citation>
</ref>
<ref id="B51">
<label>51.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamada</surname><given-names>N</given-names></name><name><surname>Seo</surname><given-names>SU</given-names></name><name><surname>Chen</surname><given-names>GY</given-names></name><name><surname>Nunez</surname><given-names>G</given-names></name></person-group>. <article-title>Role of the gut microbiota in immunity and inflammatory disease</article-title>. <source/>Nat Rev Immunol. (<year>2013</year>) <volume>13</volume>:<fpage>321</fpage>–<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1038/nri3430</pub-id><pub-id pub-id-type="pmid">23618829</pub-id></mixed-citation>
</ref>
<ref id="B52">
<label>52.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>N</given-names></name></person-group>. <article-title>Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis</article-title>. <source/>Immunity (<year>2014</year>) <volume>40</volume>:<fpage>128</fpage>–<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2013.12.007</pub-id><pub-id pub-id-type="pmid">24412617</pub-id></mixed-citation>
</ref>
<ref id="B53">
<label>53.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuchikami</surname><given-names>M</given-names></name><name><surname>Yamamoto</surname><given-names>S</given-names></name><name><surname>Morinobu</surname><given-names>S</given-names></name><name><surname>Okada</surname><given-names>S</given-names></name><name><surname>Yamawaki</surname><given-names>Y</given-names></name><name><surname>Yamawaki</surname><given-names>S</given-names></name></person-group>. <article-title>The potential use of histone deacetylase inhibitors in the treatment of depression</article-title>. <source/>Prog Neuropsychopharmacol Biol Psychiatry (<year>2016</year>) <volume>64</volume>:<fpage>320</fpage>–<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1016/j.pnpbp.2015.03.010</pub-id><pub-id pub-id-type="pmid">25818247</pub-id></mixed-citation>
</ref>
<ref id="B54">
<label>54.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeCastro</surname><given-names>M</given-names></name><name><surname>Nankova</surname><given-names>BB</given-names></name><name><surname>Shah</surname><given-names>P</given-names></name><name><surname>Patel</surname><given-names>P</given-names></name><name><surname>Mally</surname><given-names>PV</given-names></name><name><surname>Mishra</surname><given-names>R</given-names></name><etal></etal></person-group>. <article-title>Short chain fatty acids regulate tyrosine hydroxylase gene expression through a cAMP-dependent signaling pathway</article-title>. <source/>Mol Brain Res. (<year>2005</year>) <volume>142</volume>:<fpage>28</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1016/j.molbrainres.2005.09.002</pub-id><pub-id pub-id-type="pmid">16219387</pub-id></mixed-citation>
</ref>
<ref id="B55">
<label>55.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>PS</given-names></name><name><surname>Dallas</surname><given-names>S</given-names></name><name><surname>Wilson</surname><given-names>B</given-names></name><name><surname>Block</surname><given-names>ML</given-names></name><name><surname>Wang</surname><given-names>CC</given-names></name><etal></etal></person-group>. <article-title>Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons</article-title>. <source/>Int J Neuropsychopharmacol. (<year>2008</year>) <volume>11</volume>:<fpage>1123</fpage>–<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1017/S1461145708009024</pub-id><pub-id pub-id-type="pmid">18611290</pub-id></mixed-citation>
</ref>
<ref id="B56">
<label>56.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kidd</surname><given-names>SK</given-names></name><name><surname>Schneider</surname><given-names>JS</given-names></name></person-group>. <article-title>Protection of dopaminergic cells from MPP+-mediated toxicity by histone deacetylase inhibition</article-title>. <source/>Brain Res. (<year>2010</year>) <volume>1354</volume>:<fpage>172</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2010.07.041</pub-id><pub-id pub-id-type="pmid">20654591</pub-id></mixed-citation>
</ref>
<ref id="B57">
<label>57.</label>
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Wall</surname><given-names>R</given-names></name><name><surname>Cryan</surname><given-names>JF</given-names></name><name><surname>Ross</surname><given-names>RP</given-names></name><name><surname>Fitzgerald</surname><given-names>GF</given-names></name><name><surname>Dinan</surname><given-names>TG</given-names></name><name><surname>Stanton</surname><given-names>C</given-names></name></person-group>. <article-title>Bacterial neuroactive compounds produced by psychobiotics</article-title>. In: <person-group person-group-type="editor"><name><surname>Lyte</surname><given-names>M</given-names></name><name><surname>Cryan</surname><given-names>JF</given-names></name></person-group> editors. <source/>Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease.
<publisher-loc>New York, NY</publisher-loc>: <publisher-name>Springer New York</publisher-name> (<year>2014</year>). p. <fpage>221</fpage>–<lpage>39</lpage>. </mixed-citation>
</ref>
<ref id="B58">
<label>58.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheydina</surname><given-names>A</given-names></name><name><surname>Eberhardt</surname><given-names>RY</given-names></name><name><surname>Rigden</surname><given-names>DJ</given-names></name><name><surname>Chang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Zmasek</surname><given-names>CC</given-names></name><etal></etal></person-group>. <article-title>Structural genomics analysis of uncharacterized protein families overrepresented in human gut bacteria identifies a novel glycoside hydrolase</article-title>. <source/>BMC Bioinformatics (<year>2014</year>) <volume>15</volume>:<fpage>112</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2105-15-112</pub-id><pub-id pub-id-type="pmid">24742328</pub-id></mixed-citation>
</ref>
<ref id="B59">
<label>59.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duranti</surname><given-names>S</given-names></name><name><surname>Milani</surname><given-names>C</given-names></name><name><surname>Lugli</surname><given-names>GA</given-names></name><name><surname>Turroni</surname><given-names>F</given-names></name><name><surname>Mancabelli</surname><given-names>L</given-names></name><name><surname>Sanchez</surname><given-names>B</given-names></name><etal></etal></person-group>. <article-title>Insights from genomes of representatives of the human gut commensal Bifidobacterium bifidum</article-title>. <source/>Environ Microbiol. (<year>2015</year>) <volume>17</volume>:<fpage>2515</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1111/1462-2920.12743</pub-id><pub-id pub-id-type="pmid">25523018</pub-id></mixed-citation>
</ref>
<ref id="B60">
<label>60.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Ren</surname><given-names>F</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Hao</surname><given-names>Y</given-names></name><name><surname>Jin</surname><given-names>J</given-names></name><etal></etal></person-group>. <article-title>Starch and starch hydrolysates are favorable carbon sources for bifidobacteria in the human gut</article-title>. <source/>BMC Microbiol. (<year>2015</year>) <volume>15</volume>:<fpage>54</fpage>. <pub-id pub-id-type="doi">10.1186/s12866-015-0362-3</pub-id><pub-id pub-id-type="pmid">25887661</pub-id></mixed-citation>
</ref>
<ref id="B61">
<label>61.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khoroshkin</surname><given-names>MS</given-names></name><name><surname>Leyn</surname><given-names>SA</given-names></name><name><surname>Van Sinderen</surname><given-names>D</given-names></name><name><surname>Rodionov</surname><given-names>DA</given-names></name></person-group>. <article-title>Transcriptional regulation of carbohydrate utilization pathways in the bifidobacterium genus</article-title>. <source/>Front Microbiol. (<year>2016</year>) <volume>7</volume>:<fpage>120</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2016.00120</pub-id><pub-id pub-id-type="pmid">26903998</pub-id></mixed-citation>
</ref>
<ref id="B62">
<label>62.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozcan</surname><given-names>E</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Rowley</surname><given-names>DC</given-names></name><name><surname>Sela</surname><given-names>DA</given-names></name></person-group>. <article-title>A human gut commensal ferments cranberry carbohydrates to produce formate</article-title>. <source/>Appl Environ Microbiol. (<year>2017</year>) [Epub ahead of print]. <pub-id pub-id-type="doi">10.1128/AEM.01097-17</pub-id><pub-id pub-id-type="pmid">28667113</pub-id></mixed-citation>
</ref>
<ref id="B63">
<label>63.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>WSF</given-names></name><name><surname>Meijerink</surname><given-names>M</given-names></name><name><surname>Zeuner</surname><given-names>B</given-names></name><name><surname>Holck</surname><given-names>J</given-names></name><name><surname>Louis</surname><given-names>P</given-names></name><name><surname>Meyer</surname><given-names>AS</given-names></name><etal></etal></person-group>. <article-title>Prebiotic potential of pectin and pectic oligosaccharides to promote anti-inflammatory commensal bacteria in the human colon</article-title>. <source/>FEMS Microbiol Ecol. (<year>2017</year>) 93:. <pub-id pub-id-type="doi">10.1093/femsec/fix127</pub-id><pub-id pub-id-type="pmid">29029078</pub-id></mixed-citation>
</ref>
<ref id="B64">
<label>64.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>K</given-names></name><name><surname>Tesar</surname><given-names>C</given-names></name><name><surname>Wilton</surname><given-names>R</given-names></name><name><surname>Keigher</surname><given-names>L</given-names></name><name><surname>Babnigg</surname><given-names>G</given-names></name><name><surname>Joachimiak</surname><given-names>A</given-names></name></person-group>. <article-title>Novel alpha-glucosidase from human gut microbiome: substrate specificities and their switch</article-title>. <source/>FASEB J (<year>2010</year>) <volume>24</volume>:<fpage>3939</fpage>–<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1096/fj.10-156257</pub-id><pub-id pub-id-type="pmid">20581222</pub-id></mixed-citation>
</ref>
<ref id="B65">
<label>65.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mao</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Gu</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>YQ</given-names></name><etal></etal></person-group>. <article-title><italic>In vitro</italic> fermentation of fructooligosaccharides with human gut bacteria</article-title>. <source/>Food Funct. (<year>2015</year>) <volume>6</volume>:<fpage>947</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1039/C4FO01082E</pub-id><pub-id pub-id-type="pmid">25653214</pub-id></mixed-citation>
</ref>
<ref id="B66">
<label>66.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morais</surname><given-names>S</given-names></name><name><surname>Ben David</surname><given-names>Y</given-names></name><name><surname>Bensoussan</surname><given-names>L</given-names></name><name><surname>Duncan</surname><given-names>SH</given-names></name><name><surname>Koropatkin</surname><given-names>NM</given-names></name><name><surname>Martens</surname><given-names>EC</given-names></name><etal></etal></person-group>. <article-title>Enzymatic profiling of cellulosomal enzymes from the human gut bacterium, <italic>Ruminococcus champanellensis</italic>, reveals a fine-tuned system for cohesin-dockerin recognition</article-title>. <source/>Environ Microbiol. (<year>2016</year>) <volume>18</volume>:<fpage>542</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1111/1462-2920.13047</pub-id><pub-id pub-id-type="pmid">26347002</pub-id></mixed-citation>
</ref>
<ref id="B67">
<label>67.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hehemann</surname><given-names>JH</given-names></name><name><surname>Kelly</surname><given-names>AG</given-names></name><name><surname>Pudlo</surname><given-names>NA</given-names></name><name><surname>Martens</surname><given-names>EC</given-names></name><name><surname>Boraston</surname><given-names>AB</given-names></name></person-group>. <article-title>Bacteria of the human gut microbiome catabolize red seaweed glycans with carbohydrate-active enzyme updates from extrinsic microbes</article-title>. <source/>Proc Natl Acad Sci USA. (<year>2012</year>) <volume>109</volume>:<fpage>19786</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1211002109</pub-id><pub-id pub-id-type="pmid">23150581</pub-id></mixed-citation>
</ref>
<ref id="B68">
<label>68.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Chekan</surname><given-names>JR</given-names></name><name><surname>Dodd</surname><given-names>D</given-names></name><name><surname>Hong</surname><given-names>PY</given-names></name><name><surname>Radlinski</surname><given-names>L</given-names></name><name><surname>Revindran</surname><given-names>V</given-names></name><etal></etal></person-group>. <article-title>Xylan utilization in human gut commensal bacteria is orchestrated by unique modular organization of polysaccharide-degrading enzymes</article-title>. <source/>Proc Natl Acad Sci USA. (<year>2014</year>) <volume>111</volume>:<fpage>E3708</fpage>–<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1406156111</pub-id><pub-id pub-id-type="pmid">25136124</pub-id></mixed-citation>
</ref>
<ref id="B69">
<label>69.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pudlo</surname><given-names>NA</given-names></name><name><surname>Urs</surname><given-names>K</given-names></name><name><surname>Kumar</surname><given-names>SS</given-names></name><name><surname>German</surname><given-names>JB</given-names></name><name><surname>Mills</surname><given-names>DA</given-names></name><name><surname>Martens</surname><given-names>EC</given-names></name></person-group>. <article-title>Symbiotic human gut bacteria with variable metabolic priorities for host mucosal glycans</article-title>. <source/>MBio (<year>2015</year>) <volume>6</volume>:<fpage>e01282</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1128/mBio.01282-15</pub-id><pub-id pub-id-type="pmid">26556271</pub-id></mixed-citation>
</ref>
<ref id="B70">
<label>70.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Despres</surname><given-names>J</given-names></name><name><surname>Forano</surname><given-names>E</given-names></name><name><surname>Lepercq</surname><given-names>P</given-names></name><name><surname>Comtet-Marre</surname><given-names>S</given-names></name><name><surname>Jubelin</surname><given-names>G</given-names></name><name><surname>Yeoman</surname><given-names>CJ</given-names></name><etal></etal></person-group>
<article-title>Unraveling the pectinolytic function of Bacteroides xylanisolvens using a RNA-seq approach and mutagenesis</article-title>. <source/>BMC Genomics (<year>2016</year>) <volume>17</volume>:<fpage>147</fpage>
<pub-id pub-id-type="doi">10.1186/s12864-016-2472-1</pub-id><pub-id pub-id-type="pmid">26920945</pub-id></mixed-citation>
</ref>
<ref id="B71">
<label>71.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rakoff-Nahoum</surname><given-names>S</given-names></name><name><surname>Foster</surname><given-names>KR</given-names></name><name><surname>Comstock</surname><given-names>LE</given-names></name></person-group>. <article-title>The evolution of cooperation within the gut microbiota</article-title>. <source/>Nature (<year>2016</year>) <volume>533</volume>:<fpage>255</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/nature17626</pub-id><pub-id pub-id-type="pmid">27111508</pub-id></mixed-citation>
</ref>
<ref id="B72">
<label>72.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tauzin</surname><given-names>AS</given-names></name><name><surname>Kwiatkowski</surname><given-names>KJ</given-names></name><name><surname>Orlovsky</surname><given-names>NI</given-names></name><name><surname>Smith</surname><given-names>CJ</given-names></name><name><surname>Creagh</surname><given-names>AL</given-names></name><name><surname>Haynes</surname><given-names>CA</given-names></name><etal></etal></person-group>. <article-title>Molecular dissection of xyloglucan recognition in a prominent human gut symbiont</article-title>. <source/>MBio (<year>2016</year>) <volume>7</volume>:<fpage>e02134</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1128/mBio.02134-15</pub-id><pub-id pub-id-type="pmid">27118585</pub-id></mixed-citation>
</ref>
<ref id="B73">
<label>73.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tauzin</surname><given-names>AS</given-names></name><name><surname>Laville</surname><given-names>E</given-names></name><name><surname>Xiao</surname><given-names>Y</given-names></name><name><surname>Nouaille</surname><given-names>S</given-names></name><name><surname>Le Bourgeois</surname><given-names>P</given-names></name><name><surname>Heux</surname><given-names>S</given-names></name><etal></etal></person-group>. <article-title>Functional characterization of a gene locus from an uncultured gut Bacteroides conferring xylo-oligosaccharides utilization to <italic>Escherichia coli</italic></article-title>. <source/>Mol Microbiol. (<year>2016</year>) <volume>102</volume>:<fpage>579</fpage>–<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1111/mmi.13480</pub-id><pub-id pub-id-type="pmid">27573446</pub-id></mixed-citation>
</ref>
<ref id="B74">
<label>74.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ali-Ahmad</surname><given-names>A</given-names></name><name><surname>Garron</surname><given-names>ML</given-names></name><name><surname>Zamboni</surname><given-names>V</given-names></name><name><surname>Lenfant</surname><given-names>N</given-names></name><name><surname>Nurizzo</surname><given-names>D</given-names></name><name><surname>Henrissat</surname><given-names>B</given-names></name><etal></etal></person-group>. <article-title>Structural insights into a family 39 glycoside hydrolase from the gut symbiont <italic>Bacteroides cellulosilyticus</italic> WH2</article-title>. <source/>J Struct Biol. (<year>2017</year>) <volume>197</volume>:<fpage>227</fpage>–<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1016/j.jsb.2016.11.004</pub-id><pub-id pub-id-type="pmid">27890857</pub-id></mixed-citation>
</ref>
<ref id="B75">
<label>75.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costliow</surname><given-names>ZA</given-names></name><name><surname>Degnan</surname><given-names>PH</given-names></name></person-group>. <article-title>Thiamine acquisition strategies impact metabolism and competition in the gut microbe bacteroides thetaiotaomicron</article-title>. <source/>mSystems (<year>2017</year>) <volume>2</volume>:<fpage>e00116</fpage>–<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1128/mSystems.00116-17</pub-id><pub-id pub-id-type="pmid">28951891</pub-id></mixed-citation>
</ref>
<ref id="B76">
<label>76.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ndeh</surname><given-names>D</given-names></name><name><surname>Rogowski</surname><given-names>A</given-names></name><name><surname>Cartmell</surname><given-names>A</given-names></name><name><surname>Luis</surname><given-names>AS</given-names></name><name><surname>Basle</surname><given-names>A</given-names></name><name><surname>Gray</surname><given-names>J</given-names></name><etal></etal></person-group>. <article-title>Complex pectin metabolism by gut bacteria reveals novel catalytic functions</article-title>. <source/>Nature (<year>2017</year>) <volume>544</volume>:<fpage>65</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1038/nature21725</pub-id><pub-id pub-id-type="pmid">28329766</pub-id></mixed-citation>
</ref>
<ref id="B77">
<label>77.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Temple</surname><given-names>MJ</given-names></name><name><surname>Cuskin</surname><given-names>F</given-names></name><name><surname>Basle</surname><given-names>A</given-names></name><name><surname>Hickey</surname><given-names>N</given-names></name><name><surname>Speciale</surname><given-names>G</given-names></name><name><surname>Williams</surname><given-names>SJ</given-names></name><etal></etal></person-group>. <article-title>A Bacteroidetes locus dedicated to fungal 1,6-beta-glucan degradation: unique substrate conformation drives specificity of the key endo-1,6-beta-glucanase</article-title>. <source/>J Biol Chem. (<year>2017</year>) <volume>292</volume>:<fpage>10639</fpage>–<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M117.787606</pub-id><pub-id pub-id-type="pmid">28461332</pub-id></mixed-citation>
</ref>
<ref id="B78">
<label>78.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Praharaj</surname><given-names>AB</given-names></name><name><surname>Dehury</surname><given-names>B</given-names></name><name><surname>Mahapatra</surname><given-names>N</given-names></name><name><surname>Kar</surname><given-names>SK</given-names></name><name><surname>Behera</surname><given-names>SK</given-names></name></person-group>. <article-title>Molecular dynamics insights into the structure, function, and substrate binding mechanism of mucin desulfating sulfatase of gut microbe <italic>Bacteroides fragilis</italic></article-title>. <source/>J Cell Biochem. (<year>2018</year>) <volume>119</volume>:<fpage>3618</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1002/jcb.26569</pub-id><pub-id pub-id-type="pmid">29232003</pub-id></mixed-citation>
</ref>
<ref id="B79">
<label>79.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Kusuhara</surname><given-names>S</given-names></name><name><surname>Yokoi</surname><given-names>W</given-names></name><name><surname>Ito</surname><given-names>M</given-names></name><name><surname>Miyazaki</surname><given-names>K</given-names></name></person-group>. <article-title>Prebiotic potential of L-sorbose and xylitol in promoting the growth and metabolic activity of specific butyrate-producing bacteria in human fecal culture</article-title>. <source/>FEMS Microbiol Ecol. (<year>2017</year>) <volume>93</volume>:<fpage>fiw227</fpage>. <pub-id pub-id-type="doi">10.1093/femsec/fiw227</pub-id><pub-id pub-id-type="pmid">27810878</pub-id></mixed-citation>
</ref>
<ref id="B80">
<label>80.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plichta</surname><given-names>DR</given-names></name><name><surname>Juncker</surname><given-names>AS</given-names></name><name><surname>Bertalan</surname><given-names>M</given-names></name><name><surname>Rettedal</surname><given-names>E</given-names></name><name><surname>Gautier</surname><given-names>L</given-names></name><name><surname>Varela</surname><given-names>E</given-names></name><etal></etal></person-group>. <article-title>Transcriptional interactions suggest niche segregation among microorganisms in the human gut</article-title>. <source/>Nat Microbiol. (<year>2016</year>) <volume>1</volume>:<fpage>16152</fpage>. <pub-id pub-id-type="doi">10.1038/nmicrobiol.2016.152</pub-id><pub-id pub-id-type="pmid">27564131</pub-id></mixed-citation>
</ref>
<ref id="B81">
<label>81.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van den Abbeele</surname><given-names>P</given-names></name><name><surname>Belzer</surname><given-names>C</given-names></name><name><surname>Goossens</surname><given-names>M</given-names></name><name><surname>Kleerebezem</surname><given-names>M</given-names></name><name><surname>De Vos</surname><given-names>WM</given-names></name><name><surname>Thas</surname><given-names>O</given-names></name><etal></etal></person-group>. <article-title>Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an <italic>in vitro</italic> gut model</article-title>. <source/>ISME J (<year>2013</year>) <volume>7</volume>:<fpage>949</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1038/ismej.2012.158</pub-id><pub-id pub-id-type="pmid">23235287</pub-id></mixed-citation>
</ref>
<ref id="B82">
<label>82.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grondin</surname><given-names>JM</given-names></name><name><surname>Duan</surname><given-names>D</given-names></name><name><surname>Kirlin</surname><given-names>AC</given-names></name><name><surname>Abe</surname><given-names>KT</given-names></name><name><surname>Chitayat</surname><given-names>S</given-names></name><name><surname>Spencer</surname><given-names>HL</given-names></name><etal></etal></person-group>. <article-title>Diverse modes of galacto-specific carbohydrate recognition by a family 31 glycoside hydrolase from <italic>Clostridium perfringens</italic></article-title>. <source/>PLoS ONE (<year>2017</year>) <volume>12</volume>:<fpage>e0171606</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0171606</pub-id><pub-id pub-id-type="pmid">28158290</pub-id></mixed-citation>
</ref>
<ref id="B83">
<label>83.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caminero</surname><given-names>A</given-names></name><name><surname>Herran</surname><given-names>AR</given-names></name><name><surname>Nistal</surname><given-names>E</given-names></name><name><surname>Perez-Andres</surname><given-names>J</given-names></name><name><surname>Vaquero</surname><given-names>L</given-names></name><name><surname>Vivas</surname><given-names>S</given-names></name><etal></etal></person-group>. <article-title>Diversity of the cultivable human gut microbiome involved in gluten metabolism: isolation of microorganisms with potential interest for coeliac disease</article-title>. <source/>FEMS Microbiol Ecol. (<year>2014</year>) <volume>88</volume>:<fpage>309</fpage>–<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1111/1574-6941.12295</pub-id><pub-id pub-id-type="pmid">24499426</pub-id></mixed-citation>
</ref>
<ref id="B84">
<label>84.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaur</surname><given-names>H</given-names></name><name><surname>Das</surname><given-names>C</given-names></name><name><surname>Mande</surname><given-names>SS</given-names></name></person-group>. <article-title><italic>In silico</italic> analysis of putrefaction pathways in bacteria and its implication in colorectal cancer</article-title>. <source/>Front Microbiol. (<year>2017</year>) <volume>8</volume>:<fpage>2166</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2017.02166</pub-id><pub-id pub-id-type="pmid">29163445</pub-id></mixed-citation>
</ref>
<ref id="B85">
<label>85.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLuskey</surname><given-names>K</given-names></name><name><surname>Grewal</surname><given-names>JS</given-names></name><name><surname>Das</surname><given-names>D</given-names></name><name><surname>Godzik</surname><given-names>A</given-names></name><name><surname>Lesley</surname><given-names>SA</given-names></name><name><surname>Deacon</surname><given-names>AM</given-names></name><etal></etal></person-group>. <article-title>Crystal structure and activity studies of the C11 cysteine peptidase from parabacteroides merdae in the human gut microbiome</article-title>. <source/>J Biol Chem. (<year>2016</year>) <volume>291</volume>:<fpage>9482</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M115.706143</pub-id><pub-id pub-id-type="pmid">26940874</pub-id></mixed-citation>
</ref>
<ref id="B86">
<label>86.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanctuary</surname><given-names>MR</given-names></name><name><surname>Kain</surname><given-names>JN</given-names></name><name><surname>Angkustsiri</surname><given-names>K</given-names></name><name><surname>German</surname><given-names>JB</given-names></name></person-group>. <article-title>Dietary considerations in autism spectrum disorders: the potential role of protein digestion and microbial putrefaction in the gut-brain axis</article-title>. <source/>Front Nutr. (<year>2018</year>) <volume>5</volume>:<fpage>40</fpage>. <pub-id pub-id-type="doi">10.3389/fnut.2018.00040</pub-id><pub-id pub-id-type="pmid">29868601</pub-id></mixed-citation>
</ref>
<ref id="B87">
<label>87.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolfe</surname><given-names>AR</given-names></name><name><surname>Arroyo</surname><given-names>C</given-names></name><name><surname>Tedders</surname><given-names>SH</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Dai</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name></person-group>. <article-title>Dietary protein and protein-rich food in relation to severely depressed mood: A 10 year follow-up of a national cohort</article-title>. <source/>Prog Neuropsychopharmacol Biol Psychiatry (<year>2011</year>) <volume>35</volume>:<fpage>232</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.pnpbp.2010.11.011</pub-id><pub-id pub-id-type="pmid">21108982</pub-id></mixed-citation>
</ref>
<ref id="B88">
<label>88.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pooyan</surname><given-names>S</given-names></name><name><surname>Rahimi</surname><given-names>MH</given-names></name><name><surname>Mollahosseini</surname><given-names>M</given-names></name><name><surname>Khorrami-Nezhad</surname><given-names>L</given-names></name><name><surname>Nasir</surname><given-names>Y</given-names></name><name><surname>Maghbooli</surname><given-names>Z</given-names></name><etal></etal></person-group>. <article-title>A high-protein/low-fat diet may interact with vitamin D-binding protein gene variants to moderate the risk of depression in apparently healthy adults</article-title>. <source/>Lifestyle Genom. (<year>2018</year>) <volume>11</volume>:<fpage>64</fpage>–<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1159/000492497</pub-id><pub-id pub-id-type="pmid">30184533</pub-id></mixed-citation>
</ref>
<ref id="B89">
<label>89.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhandari</surname><given-names>S</given-names></name><name><surname>Larson</surname><given-names>ME</given-names></name><name><surname>Kumar</surname><given-names>N</given-names></name><name><surname>Stein</surname><given-names>D</given-names></name></person-group>. <article-title>Association of Inflammatory Bowel Disease, (IBD) with depressive symptoms in the United States population and independent predictors of depressive symptoms in an IBD population: a NHANES study</article-title>. <source/>Gut Liver (<year>2017</year>) <volume>11</volume>:<fpage>512</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.5009/gnl16347</pub-id><pub-id pub-id-type="pmid">28395506</pub-id></mixed-citation>
</ref>
<ref id="B90">
<label>90.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Said</surname><given-names>HM</given-names></name></person-group>. <article-title>Intestinal absorption of water-soluble vitamins in health and disease</article-title>. <source/>Biochem J. (<year>2011</year>) <volume>437</volume>:<fpage>357</fpage>–<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1042/BJ20110326</pub-id><pub-id pub-id-type="pmid">21749321</pub-id></mixed-citation>
</ref>
<ref id="B91">
<label>91.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwak</surname><given-names>MJ</given-names></name><name><surname>Kwon</surname><given-names>SK</given-names></name><name><surname>Yoon</surname><given-names>JK</given-names></name><name><surname>Song</surname><given-names>JY</given-names></name><name><surname>Seo</surname><given-names>JG</given-names></name><name><surname>Chung</surname><given-names>MJ</given-names></name><etal></etal></person-group>. <article-title>Evolutionary architecture of the infant-adapted group of Bifidobacterium species associated with the probiotic function</article-title>. <source/>Syst Appl Microbiol. (<year>2016</year>) <volume>39</volume>:<fpage>429</fpage>–<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1016/j.syapm.2016.07.004</pub-id><pub-id pub-id-type="pmid">27524178</pub-id></mixed-citation>
</ref>
<ref id="B92">
<label>92.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilbody</surname><given-names>S</given-names></name><name><surname>Lightfoot</surname><given-names>T</given-names></name><name><surname>Sheldon</surname><given-names>T</given-names></name></person-group>. <article-title>Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity</article-title>. <source/>J Epidemiol Community Health (<year>2007</year>) <volume>61</volume>:<fpage>631</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1136/jech.2006.050385</pub-id><pub-id pub-id-type="pmid">17568057</pub-id></mixed-citation>
</ref>
<ref id="B93">
<label>93.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beydoun</surname><given-names>MA</given-names></name><name><surname>Shroff</surname><given-names>MR</given-names></name><name><surname>Beydoun</surname><given-names>HA</given-names></name><name><surname>Zonderman</surname><given-names>AB</given-names></name></person-group>. <article-title>Serum folate, vitamin B-12, and homocysteine and their association with depressive symptoms among U.S. adults</article-title>. <source/>Psychosom Med. (<year>2010</year>) <volume>72</volume>:<fpage>862</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1097/PSY.0b013e3181f61863</pub-id><pub-id pub-id-type="pmid">20841559</pub-id></mixed-citation>
</ref>
<ref id="B94">
<label>94.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>CK</given-names></name><name><surname>Moyer</surname><given-names>MP</given-names></name><name><surname>Dudeja</surname><given-names>PK</given-names></name><name><surname>Said</surname><given-names>HM</given-names></name></person-group>. <article-title>A protein-tyrosine kinase-regulated, pH-dependent, carrier-mediated uptake system for folate in human normal colonic epithelial cell line NCM460</article-title>. <source/>J Biol Chem. (<year>1997</year>) <volume>272</volume>:<fpage>6226</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.272.10.6226</pub-id><pub-id pub-id-type="pmid">9045638</pub-id></mixed-citation>
</ref>
<ref id="B95">
<label>95.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dudeja</surname><given-names>PK</given-names></name><name><surname>Torania</surname><given-names>SA</given-names></name><name><surname>Said</surname><given-names>HM</given-names></name></person-group>. <article-title>Evidence for the existence of a carrier-mediated folate uptake mechanism in human colonic luminal membranes</article-title>. <source/>Am J Physiol. (<year>1997</year>) <volume>272</volume>(<issue>6 Pt 1</issue>): <fpage>G1408</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="pmid">9227476</pub-id></mixed-citation>
</ref>
<ref id="B96">
<label>96.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Ding</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Ye</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><etal></etal></person-group>. <article-title>Thiamine nutritional status and depressive symptoms are inversely associated among older Chinese adults</article-title>. <source/>J Nutr. (<year>2013</year>) <volume>143</volume>:<fpage>53</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.3945/jn.112.167007</pub-id><pub-id pub-id-type="pmid">23173173</pub-id></mixed-citation>
</ref>
<ref id="B97">
<label>97.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Said</surname><given-names>HM</given-names></name></person-group>. <article-title>Recent advances in carrier-mediated intestinal absorption of water-soluble vitamins</article-title>. <source/>Annu Rev Physiol. (<year>2004</year>) <volume>66</volume>:<fpage>419</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.physiol.66.032102.144611</pub-id><pub-id pub-id-type="pmid">14977409</pub-id></mixed-citation>
</ref>
<ref id="B98">
<label>98.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paerl</surname><given-names>RW</given-names></name><name><surname>Bertrand</surname><given-names>EM</given-names></name><name><surname>Rowland</surname><given-names>E</given-names></name><name><surname>Schatt</surname><given-names>P</given-names></name><name><surname>Mehiri</surname><given-names>M</given-names></name><name><surname>Niehaus</surname><given-names>TD</given-names></name><etal></etal></person-group>
<article-title>Carboxythiazole is a key microbial nutrient currency and critical component of thiamin biosynthesis</article-title>. <source/>Sci Rep. (<year>2018</year>) <volume>8</volume>:<fpage>5940</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-018-24321-2</pub-id><pub-id pub-id-type="pmid">29654239</pub-id></mixed-citation>
</ref>
<ref id="B99">
<label>99.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinto-Sanchez</surname><given-names>MI</given-names></name><name><surname>Ford</surname><given-names>AC</given-names></name><name><surname>Avila</surname><given-names>CA</given-names></name><name><surname>Verdu</surname><given-names>EF</given-names></name><name><surname>Collins</surname><given-names>SM</given-names></name><name><surname>Morgan</surname><given-names>D</given-names></name><etal></etal></person-group>. <article-title>Anxiety and depression increase in a stepwise manner in parallel with multiple FGIDs and symptom severity and frequency</article-title>. <source/>Am J Gastroenterol. (<year>2015</year>) <volume>110</volume>:<fpage>1038</fpage>. <pub-id pub-id-type="doi">10.1038/ajg.2015.128</pub-id><pub-id pub-id-type="pmid">25964226</pub-id></mixed-citation>
</ref>
<ref id="B100">
<label>100.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>A</given-names></name><name><surname>Camilleri</surname><given-names>M</given-names></name><name><surname>Burton</surname><given-names>DD</given-names></name><name><surname>Eckert</surname><given-names>DJ</given-names></name><name><surname>Pardi</surname><given-names>DS</given-names></name><name><surname>Singh</surname><given-names>RJ</given-names></name><etal></etal></person-group>
<article-title>Comparison of small bowel and colonic mucosal permeability in ulcerative/microscopic colitis, irritable bowel syndrome-diarrhea, and healthy controls by urinary saccharide excretion measurements</article-title>. <source/>Gastroenterology (<year>2011</year>) <volume>140</volume>:<fpage>S707</fpage>–<lpage>8</lpage>.</mixed-citation>
</ref>
<ref id="B101">
<label>101.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vivinus-Nebot</surname><given-names>M</given-names></name><name><surname>Dainese</surname><given-names>R</given-names></name><name><surname>Anty</surname><given-names>R</given-names></name><name><surname>Saint-Paul</surname><given-names>MC</given-names></name><name><surname>Nano</surname><given-names>JL</given-names></name><name><surname>Gonthier</surname><given-names>N</given-names></name><etal></etal></person-group>. <article-title>Combination of allergic factors can worsen diarrheic irritable bowel syndrome: role of barrier defects and mast cells</article-title>. <source/>Am J Gastroenterol. (<year>2012</year>) <volume>107</volume>:<fpage>75</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1038/ajg.2011.315</pub-id><pub-id pub-id-type="pmid">21931380</pub-id></mixed-citation>
</ref>
<ref id="B102">
<label>102.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kassinen</surname><given-names>A</given-names></name><name><surname>Krogius-Kurikka</surname><given-names>L</given-names></name><name><surname>Makivuokko</surname><given-names>H</given-names></name><name><surname>Rinttila</surname><given-names>T</given-names></name><name><surname>Paulin</surname><given-names>L</given-names></name><name><surname>Corander</surname><given-names>J</given-names></name><etal></etal></person-group>. <article-title>The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects</article-title>. <source/>Gastroenterology (<year>2007</year>) <volume>133</volume>:<fpage>24</fpage>–<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2007.04.005</pub-id><pub-id pub-id-type="pmid">17631127</pub-id></mixed-citation>
</ref>
<ref id="B103">
<label>103.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>D</given-names></name><name><surname>Ma</surname><given-names>I</given-names></name><name><surname>Ma</surname><given-names>TY</given-names></name></person-group>. <article-title>Molecular mechanism of tumor necrosis factor-α modulation of intestinal epithelial tight junction barrier</article-title>. <source/>Am J Physiol. (<year>2006</year>) <volume>290</volume>:<fpage>G496</fpage>–<lpage>504</lpage>. <pub-id pub-id-type="doi">10.1152/ajpgi.00318.2005</pub-id><pub-id pub-id-type="pmid">16474009</pub-id></mixed-citation>
</ref>
<ref id="B104">
<label>104.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bischoff</surname><given-names>SC</given-names></name><name><surname>Barbara</surname><given-names>G</given-names></name><name><surname>Buurman</surname><given-names>W</given-names></name><name><surname>Ockhuizen</surname><given-names>T</given-names></name><name><surname>Schulzke</surname><given-names>JD</given-names></name><name><surname>Serino</surname><given-names>M</given-names></name><etal></etal></person-group>. <article-title>Intestinal permeability–a new target for disease prevention and therapy</article-title>. <source/>BMC Gastroenterol. (<year>2014</year>) <volume>14</volume>:<fpage>189</fpage>. <pub-id pub-id-type="doi">10.1186/s12876-014-0189-7</pub-id><pub-id pub-id-type="pmid">25407511</pub-id></mixed-citation>
</ref>
<ref id="B105">
<label>105.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>EP</given-names></name><name><surname>Ellison</surname><given-names>MD</given-names></name><name><surname>Kontos</surname><given-names>HA</given-names></name><name><surname>Povlishock</surname><given-names>JT</given-names></name></person-group>. <article-title>O2 radicals in arachidonate-induced increased blood-brain barrier permeability to proteins</article-title>. <source/>Am J Physiol. (<year>1986</year>) <volume>251</volume>(<issue>4 Pt 2</issue>):<fpage>H693</fpage>–<lpage>99</lpage>. <pub-id pub-id-type="pmid">3094386</pub-id></mixed-citation>
</ref>
<ref id="B106">
<label>106.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Easton</surname><given-names>AS</given-names></name><name><surname>Fraser</surname><given-names>PA</given-names></name></person-group>. <article-title>Arachidonic acid increases cerebral microvascular permeability by free radicals in single pial microvessels of the anaesthetized rat</article-title>. <source/>J Physiol. (<year>1998</year>) <volume>507</volume>(<issue>Pt 2</issue>):<fpage>541</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="pmid">9518711</pub-id></mixed-citation>
</ref>
<ref id="B107">
<label>107.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marchiando</surname><given-names>AM</given-names></name><name><surname>Shen</surname><given-names>L</given-names></name><name><surname>Graham</surname><given-names>WV</given-names></name><name><surname>Edelblum</surname><given-names>KL</given-names></name><name><surname>Duckworth</surname><given-names>CA</given-names></name><name><surname>Guan</surname><given-names>Y</given-names></name><etal></etal></person-group>. <article-title>The epithelial barrier is maintained by in vivo tight junction expansion during pathologic intestinal epithelial shedding</article-title>. <source/>Gastroenterology (<year>2011</year>) <volume>140</volume>:<fpage>1208</fpage>–<lpage>18.e1</lpage>–<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2011.01.004</pub-id><pub-id pub-id-type="pmid">21237166</pub-id></mixed-citation>
</ref>
<ref id="B108">
<label>108.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maes</surname><given-names>M</given-names></name><name><surname>Song</surname><given-names>C</given-names></name><name><surname>Lin</surname><given-names>A</given-names></name><name><surname>De Jongh</surname><given-names>R</given-names></name><name><surname>Van Gastel</surname><given-names>A</given-names></name><name><surname>Kenis</surname><given-names>G</given-names></name><etal></etal></person-group>. <article-title>The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety</article-title>. <source/>Cytokine (<year>1998</year>) <volume>10</volume>:<fpage>313</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1006/cyto.1997.0290</pub-id><pub-id pub-id-type="pmid">9617578</pub-id></mixed-citation>
</ref>
<ref id="B109">
<label>109.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miura</surname><given-names>H</given-names></name><name><surname>Ozaki</surname><given-names>N</given-names></name><name><surname>Sawada</surname><given-names>M</given-names></name><name><surname>Isobe</surname><given-names>K</given-names></name><name><surname>Ohta</surname><given-names>T</given-names></name><name><surname>Nagatsu</surname><given-names>T</given-names></name></person-group>. <article-title>A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression</article-title>. <source/>Stress (<year>2008</year>) <volume>11</volume>:<fpage>198</fpage>–<lpage>209</lpage>. <pub-id pub-id-type="doi">10.1080/10253890701754068</pub-id><pub-id pub-id-type="pmid">18465467</pub-id></mixed-citation>
</ref>
<ref id="B110">
<label>110.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwarcz</surname><given-names>R</given-names></name><name><surname>Whetsell</surname><given-names>WO</given-names><suffix>Jr</suffix></name><name><surname>Mangano</surname><given-names>RM</given-names></name></person-group>. <article-title>Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain</article-title>. <source/>Science (<year>1983</year>) <volume>219</volume>:<fpage>316</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1126/science.6849138</pub-id><pub-id pub-id-type="pmid">6849138</pub-id></mixed-citation>
</ref>
<ref id="B111">
<label>111.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guillemin</surname><given-names>GJ</given-names></name></person-group>. <article-title>Quinolinic acid, the inescapable neurotoxin</article-title>. <source/>FEBS J (<year>2012</year>) <volume>279</volume>:<fpage>1356</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1111/j.1742-4658.2012.08485.x</pub-id><pub-id pub-id-type="pmid">22248144</pub-id></mixed-citation>
</ref>
<ref id="B112">
<label>112.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>BB</given-names></name><name><surname>Van Benschoten Andrew</surname><given-names>H</given-names></name><name><surname>Cimermancic</surname><given-names>P</given-names></name><name><surname>Donia</surname><given-names>MS</given-names></name><name><surname>Zimmermann</surname><given-names>M</given-names></name><name><surname>Taketani</surname><given-names>M</given-names></name><etal></etal></person-group>. <article-title>Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine</article-title>. <source/>Cell Host Microbe (<year>2014</year>) <volume>16</volume>:<fpage>495</fpage>–<lpage>503</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2014.09.001</pub-id><pub-id pub-id-type="pmid">25263219</pub-id></mixed-citation>
</ref>
<ref id="B113">
<label>113.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yunes</surname><given-names>RA</given-names></name><name><surname>Poluektova</surname><given-names>EU</given-names></name><name><surname>Dyachkova</surname><given-names>MS</given-names></name><name><surname>Klimina</surname><given-names>KM</given-names></name><name><surname>Kovtun</surname><given-names>AS</given-names></name><name><surname>Averina</surname><given-names>OV</given-names></name><etal></etal></person-group>. <article-title>GABA production and structure of gadB/gadC genes in Lactobacillus and Bifidobacterium strains from human microbiota</article-title>. <source/>Anaerobe (<year>2016</year>) <volume>42</volume>:<fpage>197</fpage>–<lpage>204</lpage>. <pub-id pub-id-type="doi">10.1016/j.anaerobe.2016.10.011</pub-id><pub-id pub-id-type="pmid">27794467</pub-id></mixed-citation>
</ref>
<ref id="B114">
<label>114.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Mahony</surname><given-names>SM</given-names></name><name><surname>Clarke</surname><given-names>G</given-names></name><name><surname>Borre</surname><given-names>YE</given-names></name><name><surname>Dinan</surname><given-names>TG</given-names></name><name><surname>Cryan</surname><given-names>JF</given-names></name></person-group>. <article-title>Serotonin, tryptophan metabolism and the brain-gut-microbiome axis</article-title>. <source/>Behav Brain Res. (<year>2015</year>) <volume>277</volume>:<fpage>32</fpage>–<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2014.07.027</pub-id><pub-id pub-id-type="pmid">25078296</pub-id></mixed-citation>
</ref>
<ref id="B115">
<label>115.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>WH</given-names></name><name><surname>Chuang</surname><given-names>HL</given-names></name><name><surname>Huang</surname><given-names>YT</given-names></name><name><surname>Wu</surname><given-names>CC</given-names></name><name><surname>Chou</surname><given-names>GT</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><etal></etal></person-group>. <article-title>Alteration of behavior and monoamine levels attributable to Lactobacillus plantarum PS128 in germ-free mice</article-title>. <source/>Behav Brain Res. (<year>2016</year>) <volume>298</volume>(<issue>Pt B</issue>):<fpage>202</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2015.10.046</pub-id><pub-id pub-id-type="pmid">26522841</pub-id></mixed-citation>
</ref>
<ref id="B116">
<label>116.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bercik</surname><given-names>P</given-names></name><name><surname>Park</surname><given-names>AJ</given-names></name><name><surname>Sinclair</surname><given-names>D</given-names></name><name><surname>Khoshdel</surname><given-names>A</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><etal></etal></person-group>. <article-title>The anxiolytic effect of <italic>Bifidobacterium longum</italic> NCC3001 involves vagal pathways for gut–brain communication</article-title>. <source/>Neurogastroenterol Motil. (<year>2011</year>) <volume>23</volume>:<fpage>1132</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2982.2011.01796.x</pub-id><pub-id pub-id-type="pmid">21988661</pub-id></mixed-citation>
</ref>
<ref id="B117">
<label>117.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bravo</surname><given-names>JA</given-names></name><name><surname>Forsythe</surname><given-names>P</given-names></name><name><surname>Chew</surname><given-names>MV</given-names></name><name><surname>Escaravage</surname><given-names>E</given-names></name><name><surname>Savignac</surname><given-names>HM</given-names></name><name><surname>Dinan</surname><given-names>TG</given-names></name><etal></etal></person-group>. <article-title>Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve</article-title>. <source/>Proc Natl Acad Sci USA. (<year>2011</year>) <volume>108</volume>:<fpage>16050</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1102999108</pub-id><pub-id pub-id-type="pmid">21876150</pub-id></mixed-citation>
</ref>
<ref id="B118">
<label>118.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandez-Real</surname><given-names>JM</given-names></name><name><surname>Serino</surname><given-names>M</given-names></name><name><surname>Blasco</surname><given-names>G</given-names></name><name><surname>Puig</surname><given-names>J</given-names></name><name><surname>Daunis-i-Estadella</surname><given-names>J</given-names></name><name><surname>Ricart</surname><given-names>W</given-names></name><etal></etal></person-group>. <article-title>Gut Microbiota Interacts With Brain Microstructure and Function</article-title>. <source/>J Clin Endocrinol Metab. (<year>2015</year>) <volume>100</volume>:<fpage>4505</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2015-3076</pub-id><pub-id pub-id-type="pmid">26445114</pub-id></mixed-citation>
</ref>
<ref id="B119">
<label>119.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tillisch</surname><given-names>K</given-names></name><name><surname>Mayer</surname><given-names>E</given-names></name><name><surname>Gupta</surname><given-names>A</given-names></name><name><surname>Gill</surname><given-names>Z</given-names></name><name><surname>Brazeilles</surname><given-names>R</given-names></name><name><surname>Le Neve</surname><given-names>B</given-names></name><etal></etal></person-group>. <article-title>Brain structure and response to emotional stimuli as related to gut microbial profiles in healthy women</article-title>. <source/>Psychosom Med. (<year>2017</year>) <volume>79</volume>:<fpage>905</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1097/PSY.0000000000000493</pub-id><pub-id pub-id-type="pmid">28661940</pub-id></mixed-citation>
</ref>
<ref id="B120">
<label>120.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tillisch</surname><given-names>K</given-names></name><name><surname>Labus</surname><given-names>J</given-names></name><name><surname>Kilpatrick</surname><given-names>L</given-names></name><name><surname>Jiang</surname><given-names>Z</given-names></name><name><surname>Stains</surname><given-names>J</given-names></name><name><surname>Ebrat</surname><given-names>B</given-names></name><etal></etal></person-group>. <article-title>Consumption of fermented milk product with probiotic modulates brain activity</article-title>. <source/>Gastroenterology (<year>2013</year>) <volume>144</volume>:<fpage>1394</fpage>–<lpage>401</lpage>. 1401.e1391–4. <pub-id pub-id-type="doi">10.1053/j.gastro.2013.02.043</pub-id><pub-id pub-id-type="pmid">23474283</pub-id></mixed-citation>
</ref>
<ref id="B121">
<label>121.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinto-Sanchez</surname><given-names>MI</given-names></name><name><surname>Hall</surname><given-names>GB</given-names></name><name><surname>Ghajar</surname><given-names>K</given-names></name><name><surname>Nardelli</surname><given-names>A</given-names></name><name><surname>Bolino</surname><given-names>C</given-names></name><name><surname>Lau</surname><given-names>JT</given-names></name><etal></etal></person-group>. <article-title>Probiotic <italic>Bifidobacterium longum</italic> NCC3001 reduces depression scores and alters brain activity: a pilot study in patients with irritable bowel syndrome</article-title>. <source/>Gastroenterology (<year>2017</year>) <volume>153</volume>:<fpage>448</fpage>–<lpage>59</lpage>.e8. <pub-id pub-id-type="doi">10.1053/j.gastro.2017.05.003</pub-id><pub-id pub-id-type="pmid">28483500</pub-id></mixed-citation>
</ref>
<ref id="B122">
<label>122.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshioka</surname><given-names>H</given-names></name><name><surname>Iseki</surname><given-names>K</given-names></name><name><surname>Fujita</surname><given-names>K</given-names></name></person-group>. <article-title>Development and differences of intestinal flora in the neonatal period in breast-fed and bottle-fed infants</article-title>. <source/>Pediatrics (<year>1983</year>) <volume>72</volume>:<fpage>317</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="pmid">6412205</pub-id></mixed-citation>
</ref>
<ref id="B123">
<label>123.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>PY</given-names></name><name><surname>Huang</surname><given-names>SY</given-names></name><name><surname>Su</surname><given-names>KP</given-names></name></person-group>. <article-title>A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression</article-title>. <source/>Biol Psychiatry (<year>2010</year>) <volume>68</volume>:<fpage>140</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2010.03.018</pub-id><pub-id pub-id-type="pmid">20452573</pub-id></mixed-citation>
</ref>
<ref id="B124">
<label>124.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>JJ</given-names></name><name><surname>Green</surname><given-names>P</given-names></name><name><surname>John Mann</surname><given-names>J</given-names></name><name><surname>Rapoport</surname><given-names>SI</given-names></name><name><surname>Sublette</surname><given-names>ME</given-names></name></person-group>. <article-title>Pathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease</article-title>. <source/>Brain Res. (<year>2015</year>) <volume>1597</volume>:<fpage>220</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2014.11.059</pub-id><pub-id pub-id-type="pmid">25498862</pub-id></mixed-citation>
</ref>
<ref id="B125">
<label>125.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kankaanpää</surname><given-names>PE</given-names></name><name><surname>Salminen</surname><given-names>SJ</given-names></name><name><surname>Isolauri</surname><given-names>E</given-names></name><name><surname>Lee</surname><given-names>YK</given-names></name></person-group>. <article-title>The influence of polyunsaturated fatty acids on probiotic growth and adhesion</article-title>. <source/>FEMS Microbiol Lett. (<year>2001</year>) <volume>194</volume>:<fpage>149</fpage>–<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1111/j.1574-6968.2001.tb09460.x</pub-id><pub-id pub-id-type="pmid">11164299</pub-id></mixed-citation>
</ref>
<ref id="B126">
<label>126.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bomba</surname><given-names>A</given-names></name><name><surname>Nemcova</surname><given-names>R</given-names></name><name><surname>Gancarcikova</surname><given-names>S</given-names></name><name><surname>Herich</surname><given-names>R</given-names></name><name><surname>Guba</surname><given-names>P</given-names></name><name><surname>Mudronova</surname><given-names>D</given-names></name></person-group>. <article-title>Improvement of the probiotic effect of micro-organisms by their combination with maltodextrins, fructo-oligosaccharides and polyunsaturated fatty acids</article-title>. <source/>Br J Nutr. (<year>2002</year>) <volume>88</volume>(<issue>Suppl. 1</issue>):<fpage>S95</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1079/BJN2002634</pub-id><pub-id pub-id-type="pmid">12215187</pub-id></mixed-citation>
</ref>
<ref id="B127">
<label>127.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohtsuka</surname><given-names>Y</given-names></name><name><surname>Yamashiro</surname><given-names>Y</given-names></name><name><surname>Shimizu</surname><given-names>T</given-names></name><name><surname>Nagata</surname><given-names>S</given-names></name><name><surname>Igarashi</surname><given-names>J</given-names></name><name><surname>Shinohara</surname><given-names>K</given-names></name><etal></etal></person-group>. <article-title>Reducing cell membrane n-6 fatty acids attenuate mucosal damage in food-sensitive enteropathy in mice</article-title>. <source/>Pediatr Res. (<year>1997</year>) <volume>42</volume>:<fpage>835</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1203/00006450-199712000-00019</pub-id><pub-id pub-id-type="pmid">9396566</pub-id></mixed-citation>
</ref>
<ref id="B128">
<label>128.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Druart</surname><given-names>C</given-names></name><name><surname>Dewulf</surname><given-names>EM</given-names></name><name><surname>Cani</surname><given-names>PD</given-names></name><name><surname>Neyrinck</surname><given-names>AM</given-names></name><name><surname>Thissen</surname><given-names>JP</given-names></name><name><surname>Delzenne</surname><given-names>NM</given-names></name></person-group>. <article-title>Gut microbial metabolites of polyunsaturated fatty acids correlate with specific fecal bacteria and serum markers of metabolic syndrome in obese women</article-title>. <source/>Lipids (<year>2014</year>) <volume>49</volume>:<fpage>397</fpage>–<lpage>402</lpage>. <pub-id pub-id-type="doi">10.1007/s11745-014-3881-z</pub-id><pub-id pub-id-type="pmid">24473752</pub-id></mixed-citation>
</ref>
<ref id="B129">
<label>129.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raimondi</surname><given-names>S</given-names></name><name><surname>Amaretti</surname><given-names>A</given-names></name><name><surname>Leonardi</surname><given-names>A</given-names></name><name><surname>Quartieri</surname><given-names>A</given-names></name><name><surname>Gozzoli</surname><given-names>C</given-names></name><name><surname>Rossi</surname><given-names>M</given-names></name></person-group>. <article-title>Conjugated linoleic acid production by bifidobacteria: screening, kinetic, and composition</article-title>. <source/>Biomed Res Int. (<year>2016</year>) <volume>2016</volume>:<fpage>8654317</fpage>. <pub-id pub-id-type="doi">10.1155/2016/8654317</pub-id><pub-id pub-id-type="pmid">27429985</pub-id></mixed-citation>
</ref>
<ref id="B130">
<label>130.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>W</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name></person-group>
<article-title>Current state and applications of microbial genome-scale metabolic models</article-title>. <source/>Curr Opin Syst Biol. (<year>2017</year>) <volume>2</volume>:<fpage>10</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.coisb.2017.03.001</pub-id></mixed-citation>
</ref>
<ref id="B131">
<label>131.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bordbar</surname><given-names>A</given-names></name><name><surname>Monk</surname><given-names>JM</given-names></name><name><surname>King</surname><given-names>ZA</given-names></name><name><surname>Palsson</surname><given-names>BO</given-names></name></person-group>. <article-title>Constraint-based models predict metabolic and associated cellular functions</article-title>. <source/>Nat Rev Genet. (<year>2014</year>) <volume>15</volume>:<fpage>107</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1038/nrg3643</pub-id><pub-id pub-id-type="pmid">24430943</pub-id></mixed-citation>
</ref>
<ref id="B132">
<label>132.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCloskey</surname><given-names>D</given-names></name><name><surname>Palsson</surname><given-names>BO</given-names></name><name><surname>Feist</surname><given-names>AM</given-names></name></person-group>. <article-title>Basic and applied uses of genome-scale metabolic network reconstructions of <italic>Escherichia coli</italic></article-title>. <source/>Mol Syst Biol. (<year>2013</year>) <volume>9</volume>:<fpage>661</fpage>. <pub-id pub-id-type="doi">10.1038/msb.2013.18</pub-id><pub-id pub-id-type="pmid">23632383</pub-id></mixed-citation>
</ref>
<ref id="B133">
<label>133.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quince</surname><given-names>C</given-names></name><name><surname>Walker</surname><given-names>AW</given-names></name><name><surname>Simpson</surname><given-names>JT</given-names></name><name><surname>Loman</surname><given-names>NJ</given-names></name><name><surname>Segata</surname><given-names>N</given-names></name></person-group>
<article-title>Shotgun metagenomics, from sampling to analysis</article-title>. <source/>Nat Biotechnol. (<year>2017</year>) <volume>35</volume>:<fpage>833</fpage>–<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.3935</pub-id><pub-id pub-id-type="pmid">28898207</pub-id></mixed-citation>
</ref>
<ref id="B134">
<label>134.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korem</surname><given-names>T</given-names></name><name><surname>Zeevi</surname><given-names>D</given-names></name><name><surname>Suez</surname><given-names>J</given-names></name><name><surname>Weinberger</surname><given-names>A</given-names></name><name><surname>Avnit-Sagi</surname><given-names>T</given-names></name><name><surname>Pompan-Lotan</surname><given-names>M</given-names></name><etal></etal></person-group>. <article-title>Growth dynamics of gut microbiota in health and disease inferred from single metagenomic samples</article-title>. <source/>Science (<year>2015</year>) <volume>349</volume>:<fpage>1101</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1126/science.aac4812</pub-id><pub-id pub-id-type="pmid">26229116</pub-id></mixed-citation>
</ref>
<ref id="B135">
<label>135.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maier</surname><given-names>L</given-names></name><name><surname>Pruteanu</surname><given-names>M</given-names></name><name><surname>Kuhn</surname><given-names>M</given-names></name><name><surname>Zeller</surname><given-names>G</given-names></name><name><surname>Telzerow</surname><given-names>A</given-names></name><name><surname>Anderson</surname><given-names>EE</given-names></name><etal></etal></person-group>. <article-title>Extensive impact of non-antibiotic drugs on human gut bacteria</article-title>. <source/>Nature (<year>2018</year>) <volume>555</volume>:<fpage>623</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/nature25979</pub-id><pub-id pub-id-type="pmid">29555994</pub-id></mixed-citation>
</ref>
<ref id="B136">
<label>136.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cueva</surname><given-names>C</given-names></name><name><surname>Gil-Sanchez</surname><given-names>I</given-names></name><name><surname>Ayuda-Duran</surname><given-names>B</given-names></name><name><surname>Gonzalez-Manzano</surname><given-names>S</given-names></name><name><surname>Gonzalez-Paramas</surname><given-names>AM</given-names></name><name><surname>Santos-Buelga</surname><given-names>C</given-names></name><etal></etal></person-group>. <article-title>An integrated view of the effects of wine polyphenols and their relevant metabolites on gut and host health</article-title>. <source/>Molecules (<year>2017</year>) <volume>22</volume>:<fpage>E99</fpage>. <pub-id pub-id-type="doi">10.3390/molecules22010099</pub-id><pub-id pub-id-type="pmid">28067835</pub-id></mixed-citation>
</ref>
<ref id="B137">
<label>137.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falony</surname><given-names>G</given-names></name><name><surname>Joossens</surname><given-names>M</given-names></name><name><surname>Vieira-Silva</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Darzi</surname><given-names>Y</given-names></name><name><surname>Faust</surname><given-names>K</given-names></name><etal></etal></person-group>. <article-title>Population-level analysis of gut microbiome variation</article-title>. <source/>Science (<year>2016</year>) <volume>352</volume>:<fpage>560</fpage>–<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1126/science.aad3503</pub-id><pub-id pub-id-type="pmid">27126039</pub-id></mixed-citation>
</ref>
<ref id="B138">
<label>138.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhernakova</surname><given-names>A</given-names></name><name><surname>Kurilshikov</surname><given-names>A</given-names></name><name><surname>Bonder</surname><given-names>MJ</given-names></name><name><surname>Tigchelaar</surname><given-names>EF</given-names></name><name><surname>Schirmer</surname><given-names>M</given-names></name><name><surname>Vatanen</surname><given-names>T</given-names></name><etal></etal></person-group>. <article-title>Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity</article-title>. <source/>Science (<year>2016</year>) <volume>352</volume>:<fpage>565</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1126/science.aad3369</pub-id><pub-id pub-id-type="pmid">27126040</pub-id></mixed-citation>
</ref>
<ref id="B139">
<label>139.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>TN</given-names></name><name><surname>Sharma</surname><given-names>K</given-names></name><name><surname>Oh</surname><given-names>EC</given-names></name><name><surname>Liu</surname><given-names>YP</given-names></name><name><surname>Collins</surname><given-names>RL</given-names></name><name><surname>Sosa</surname><given-names>MX</given-names></name><etal></etal></person-group>. <article-title>Loss of δ-catenin function in severe autism</article-title>. <source/>Nature (<year>2015</year>) <volume>520</volume>:<fpage>51</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/nature14186</pub-id><pub-id pub-id-type="pmid">25807484</pub-id></mixed-citation>
</ref>
<ref id="B140">
<label>140.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pullabhatla</surname><given-names>V</given-names></name><name><surname>Roberts</surname><given-names>AL</given-names></name><name><surname>Lewis</surname><given-names>MJ</given-names></name><name><surname>Mauro</surname><given-names>D</given-names></name><name><surname>Morris</surname><given-names>DL</given-names></name><name><surname>Odhams</surname><given-names>CA</given-names></name><etal></etal></person-group>. <article-title><italic>De novo</italic> mutations implicate novel genes in systemic lupus erythematosus</article-title>. <source/>Hum Mol Genet. (<year>2018</year>) <volume>27</volume>:<fpage>421</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddx407</pub-id><pub-id pub-id-type="pmid">29177435</pub-id></mixed-citation>
</ref>
<ref id="B141">
<label>141.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shankar</surname><given-names>J</given-names></name></person-group>. <article-title>Insights into study design and statistical analyses in translational microbiome studies</article-title>. <source/>Ann Transl Med. (<year>2017</year>) <volume>5</volume>:<fpage>249</fpage>. <pub-id pub-id-type="doi">10.21037/atm.2017.01.13</pub-id><pub-id pub-id-type="pmid">28706917</pub-id></mixed-citation>
</ref>
<ref id="B142">
<label>142.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamilton</surname><given-names>M</given-names></name></person-group>. <article-title>A rating scale for depression</article-title>. <source/>J Neurol Neurosurg Psychol. (<year>1960</year>) <volume>23</volume>:<fpage>56</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp.23.1.56</pub-id><pub-id pub-id-type="pmid">14399272</pub-id></mixed-citation>
</ref>
<ref id="B143">
<label>143.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beck</surname><given-names>AT</given-names></name><name><surname>Ward</surname><given-names>CH</given-names></name><name><surname>Mendelson</surname><given-names>M</given-names></name><name><surname>Mock</surname><given-names>J</given-names></name><name><surname>Erbauh</surname><given-names>J</given-names></name></person-group>. <article-title>An inventory for measuring depression</article-title>. <source/>Arch Gen Psychiatry (<year>1961</year>) <volume>4</volume>:<fpage>53</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.1961.01710120031004</pub-id><pub-id pub-id-type="pmid">13688369</pub-id></mixed-citation>
</ref>
<ref id="B144">
<label>144.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guenther</surname><given-names>PM</given-names></name><name><surname>Casavale</surname><given-names>KO</given-names></name><name><surname>Reedy</surname><given-names>J</given-names></name><name><surname>Kirkpatrick</surname><given-names>SI</given-names></name><name><surname>Hiza</surname><given-names>HA</given-names></name><name><surname>Kuczynski</surname><given-names>KJ</given-names></name><etal></etal></person-group>. <article-title>Update of the healthy eating index: HEI-2010</article-title>. <source/>J Acad Nutr Diet (<year>2013</year>) <volume>113</volume>:<fpage>569</fpage>–<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/j.jand.2012.12.016</pub-id><pub-id pub-id-type="pmid">23415502</pub-id></mixed-citation>
</ref>
<ref id="B145">
<label>145.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowyer</surname><given-names>RCE</given-names></name><name><surname>Jackson</surname><given-names>MA</given-names></name><name><surname>Pallister</surname><given-names>T</given-names></name><name><surname>Skinner</surname><given-names>J</given-names></name><name><surname>Spector</surname><given-names>TD</given-names></name><name><surname>Welch</surname><given-names>AA</given-names></name><etal></etal></person-group>. <article-title>Use of dietary indices to control for diet in human gut microbiota studies</article-title>. <source/>Microbiome (<year>2018</year>) <volume>6</volume>:<fpage>77</fpage>. <pub-id pub-id-type="doi">10.1186/s40168-018-0455-y</pub-id><pub-id pub-id-type="pmid">29695307</pub-id></mixed-citation>
</ref>
<ref id="B146">
<label>146.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cenit</surname><given-names>MC</given-names></name><name><surname>Sanz</surname><given-names>Y</given-names></name><name><surname>Codoner-Franch</surname><given-names>P</given-names></name></person-group>. <article-title>Influence of gut microbiota on neuropsychiatric disorders</article-title>. <source/>World J Gastroenterol. (<year>2017</year>) <volume>23</volume>:<fpage>5486</fpage>–<lpage>98</lpage>. <pub-id pub-id-type="doi">10.3748/wjg.v23.i30.5486</pub-id><pub-id pub-id-type="pmid">28852308</pub-id></mixed-citation>
</ref>
<ref id="B147">
<label>147.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vuong</surname><given-names>HE</given-names></name><name><surname>Hsiao</surname><given-names>EY</given-names></name></person-group>. <article-title>Emerging roles for the gut microbiome in autism spectrum disorder</article-title>. <source/>Biol Psychiatry (<year>2017</year>) <volume>81</volume>:<fpage>411</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2016.08.024</pub-id><pub-id pub-id-type="pmid">27773355</pub-id></mixed-citation>
</ref>
<ref id="B148">
<label>148.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>TT</given-names></name><name><surname>Kosciolek</surname><given-names>T</given-names></name><name><surname>Eyler</surname><given-names>LT</given-names></name><name><surname>Knight</surname><given-names>R</given-names></name><name><surname>Jeste</surname><given-names>DV</given-names></name></person-group>. <article-title>Overview and systematic review of studies of microbiome in schizophrenia and bipolar disorder</article-title>. <source/>J Psychiatr Res. (<year>2018</year>) <volume>99</volume>:<fpage>50</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpsychires.2018.01.013</pub-id><pub-id pub-id-type="pmid">29407287</pub-id></mixed-citation>
</ref>
<ref id="B149">
<label>149.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swidsinski</surname><given-names>A</given-names></name><name><surname>Loening-Baucke</surname><given-names>V</given-names></name><name><surname>Lochs</surname><given-names>H</given-names></name><name><surname>Hale</surname><given-names>LP</given-names></name></person-group>. <article-title>Spatial organization of bacterial flora in normal and inflamed intestine: a fluorescence in situ hybridization study in mice</article-title>. <source/>World J Gastroenterol. (<year>2005</year>) <volume>11</volume>:<fpage>1131</fpage>–<lpage>40</lpage>. <pub-id pub-id-type="doi">10.3748/wjg.v11.i8.1131</pub-id><pub-id pub-id-type="pmid">15754393</pub-id></mixed-citation>
</ref>
<ref id="B150">
<label>150.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nani</surname><given-names>BD</given-names></name><name><surname>Lima</surname><given-names>PO</given-names></name><name><surname>Marcondes</surname><given-names>FK</given-names></name><name><surname>Groppo</surname><given-names>FC</given-names></name><name><surname>Rolim</surname><given-names>GS</given-names></name><name><surname>Moraes</surname><given-names>AB</given-names></name><etal></etal></person-group>. <article-title>Changes in salivary microbiota increase volatile sulfur compounds production in healthy male subjects with academic-related chronic stress</article-title>. <source/>PLoS ONE (<year>2017</year>) <volume>12</volume>:<fpage>e0173686</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0173686</pub-id><pub-id pub-id-type="pmid">28319129</pub-id></mixed-citation>
</ref>
<ref id="B151">
<label>151.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamb</surname><given-names>AL</given-names></name><name><surname>Hess</surname><given-names>DE</given-names></name><name><surname>Edenborn</surname><given-names>S</given-names></name><name><surname>Ubinger</surname><given-names>E</given-names></name><name><surname>Carrillo</surname><given-names>AE</given-names></name><name><surname>Appasamy</surname><given-names>PM</given-names></name></person-group>. <article-title>Elevated salivary IgA, decreased anxiety, and an altered oral microbiota are associated with active participation on an undergraduate athletic team</article-title>. <source/>Physiol Behav. (<year>2017</year>) <volume>169</volume>:<fpage>169</fpage>–<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1016/j.physbeh.2016.12.004</pub-id><pub-id pub-id-type="pmid">27932242</pub-id></mixed-citation>
</ref>
<ref id="B152">
<label>152.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiao</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>M</given-names></name><name><surname>Feng</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>F</given-names></name></person-group>. <article-title>Alterations of oral microbiota distinguish children with autism spectrum disorders from healthy controls</article-title>. <source/>Sci Rep. (<year>2018</year>) <volume>8</volume>:<fpage>1597</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-018-19982-y</pub-id><pub-id pub-id-type="pmid">29371629</pub-id></mixed-citation>
</ref>
<ref id="B153">
<label>153.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez</surname><given-names>A</given-names></name><name><surname>Hyde</surname><given-names>E</given-names></name><name><surname>Sangwan</surname><given-names>N</given-names></name><name><surname>Gilbert</surname><given-names>JA</given-names></name><name><surname>Viirre</surname><given-names>E</given-names></name><name><surname>Knight</surname><given-names>R</given-names></name><etal></etal></person-group>. <article-title>Migraines are correlated with higher levels of Nitrate-, Nitrite-, and Nitric Oxide-reducing oral microbes in the american gut project cohort</article-title>. <source/>mSystems (<year>2016</year>) <volume>1</volume>:<fpage>1</fpage>–<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1128/mSystems.00105-16</pub-id><pub-id pub-id-type="pmid">27822557</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>